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however.
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1Introduction
Working with laboratory animals
Animals have been used in scientific study since antique times. Alkmaion from Kroton,
a pupil of Pythagoras, is mentioned as the first to perform scientific dissections, as
early as 500 B.C. (96). The animals most commonly studied in biological and medical
education, research and industry today are rats and mice. In Sweden, by law (The
Animal Protection Act 1988:534 and the Animal Protection Ordinance 1988:539),
records are kept on animal research, work with animals is regulated by strict rules, and
all personnel working with animals are required to participate in educational
programmes. Intended use of animals must be approved of by the local ethical review
committees on animal experiments, of which half are scientists and half are laymen.
Between 160 000 to 190 000 mice and rats, respectively, are used yearly according to
the Swedish definition of experimental animal usage. Table 1 shows the number and
species of animals used between 1990 - 1995 (77, 78). According to the definition in
ÒCouncil of Europe convention for the protection for vertebrate animals used for
experimental and other scientific purposesÓ (ETS 123), animals that are used in for
instance studies of caring or feeding systems or behavioral studies without infliction of
suffering, or animals bred for post-mortem extraction of organs, are not defined as
experimental animals. Thus, the latter statistics provide an underestimation of the
numbers of animals to which personnel are exposed.
According to estimations, about 90 000 people work with laboratory animals in the
USA (71), 32 000 in the UK (22) and 4600 in the Netherlands (45). In Sweden, in
1995, 4000 had undergone the mandatory course for work with laboratory animals.
Furthermore, 1500 veterinarians may have occupational small animal exposure (107),
as most pet shop staff.
Rodents are also common as pets. In a study of about 2000 Swedish school children,
19% answered that they owned small fur animals (of which about half were rabbits), to
which other family members are presumably also exposed (5).
Allergy to laboratory animals
Laboratory animal allergy (LAA) is today a well-documented world-wide health hazard
among animal exposed personnel (51, 66). Allergy is defined as hypersensitivity due to
an incongruous immune reaction to a harmless substance (as opposed to appropriate
immune reactions to for instance harmful bacteria). John Bostock found and described,
in an inventory of London clinics in 1828, 27 subjects with hay fever (57). In 1873,
Blackley proved the connection between symptoms and pollen exposure. Pollen was
captured on sticky surfaces on a kite, flown at different hights, and skin and nasal
provocation tests were performed out of the pollen season, not much differently than
today (57). The first descriptions of allergy to laboratory animals are case studies (87,
106). In these and subsequent studies, LAA is characterised as an immediate type I IgE
mediated allergy, causing symptoms at contact with laboratory animals, such as
rodents.
2Table 1. Number of experimental animals used in Sweden according to the Swedish
definition 1990-1995 (77, 78).
Species 1990 1991 1992 1993 1994 1995
Mice 153 000 160 732 171 099 193 560 195 195 185 543
Rats 188 000 182 686 178 039 175 438 171 029 160 627
Guinea pigs 15 100 16 014 16 294 19 581 16 864 15 681
Other rodents 3 770 3 383 3 625 2 785 2 728 1 299
Rabbits 9 870 8 964 8 547 7 614 7 578 8 006
Primates 690 539 621 300 203 169
Dogs 670 643 873 558 700 797
Cats 690 625 547 471 394 272
Other
carnivores
3 360 116 158 122 388 220
Horses,
donkeys and
mules
110 11 23 41 76 30
Swine 5 380 6 345 5 363 6 057 6 473 5 761
Goats and
sheep
500 246 672 421 246 139
Cattle 540 593 1 151 762 929 945
Other
mammals
170 68 87 306 757 642
Birds1 98 000 103 952 140 298 180 490 200 727 153 651
Reptiles 0 180 15 55 72 8
Amphibians 3 090 2 866 2 279  2 873 1 892 1 104
Fish 10 700 14 983 22 446 25 403 22 627 23 096
Cyclostomes 290 467 630 532 708 620
Total
(Swedish
definition)
494 100 503 763 553 017 617 619 629 586 558 610
Total (ETS
definition)
338 343 347 732 349 235 351 150 351 615 331 201
1 of which about 90% were used in either behavioral studies, primarily for the
development of alternatives to cage-keeping of hens, or for the extraction of hyaluronic
acid from cocks combs.
Symptoms to laboratory animals
Symptoms to laboratory animals usually appear immediately at exposure; Lutsky found
that 93% of 191 patients experienced symptoms within 10 minutes (68). The first
symptoms of LAA to appear are usually sneezing, runny or blocked nose (rhinitis) (2,
27). These symptoms are also the most common, often in combination with swollen,
itchy or runny eyes (conjuctivitis) (51). Up to half of the symptomatics also develop
asthma symptoms; cough, wheezing, tightness of the chest. Some asthmatic subjects
also have a late phase bronchocontriction (42, 73). Skin symptoms are common,
especially contact urticaria (hives) provoked by contact with the tail or urine, or giving
wealing of the skin if lightly scratched by the animal; more infrequently angioedema (3,
51). Sometimes a more persistant eczema is seen, however, some cases might be
attributed to for instance use of gloves and latex allergy, which is fairly common among
3glove users (124). Also, itching of the palate has been described and occurred in 38%
of symptomatics in one study (68). Fortunately, anaphylaxis, with generalised swelling
and severe systemic effects is rare, but has been described in connection with for
instance animal bites (44, 62, 114, 122). About half of the patients have two or more
symptoms (6, 46, 51).
LAA prevalence and incidence
A large number of epidemiological studies have been carried out since the mid-70Õs, see
table 2. The subjects under study have differed as have the definitions of LAA, but the
reported prevalence of any symptoms has been 11-56%, and 3-13% had laboratory
animal work associated asthma (32). Many studies have included medical examination
to verify reported symptoms, for instance skin prick tests or measurements of specific
IgE in serum. Sensitization rates and how well they correlate with reported symptoms
have varied, partially depending on the methods, cut-off values and extracts used.
Nevertheless, prevalence of sensitization to laboratory animal allergens in cross-
sectional studies are between 10-62%, see table 2. Rats and mice, to which most
laboratory animal workers are exposed, are also responsible for the majority of
laboratory animal allergy (LAA) cases.
A small number of prospective studies have been carried out, and present one-year
cumulative incidences of 9-37% (16, 17, 27) and 2-year cumulative incidences of 12%
(17) and 13% (54). The yearly incidence of LAA asthma development is about 2% in
exposed subjects (27). Lincoln et al (62) also noted that several subjects did not develop
seasonal hay fever until they experienced symptoms related to their work with animals,
and in some subjects, existing pollen allergy was exacerbated by exposure to laboratory
animals.
Most LAA subjects develop their symptoms during the first three years of
occupational exposure, but it may take only weeks or up to decades. The mean or
median time for development of allergic symptoms is between 0.5-3 years (6, 16, 25,
42, 68, 102). However, in one retrospective study, the median time until development
of LAA was approximately 8.2 years in non-atopics and 2.2 years in atopics (58). Thus
the presence of atopy will influence the development of sensitization and symptoms.
The role of atopy and other host factors
Atopy is usually defined as a (genetic) predisposition to develop allergic symptoms to
common environmental allergens. The operative definitions of atopy used in studies of
allergy vary, and several LAA studies have used or compared more than one definition,
for instance presence of allergy in the family, personal allergy or skin prick test
positivity to common aeroallergens (103). Family allergy is in some studies
significantly associated with LAA (6, 99), but not in others (103, 113). Having a
personal history of allergy prior to occupational laboratory animal exposure seems a
better risk indicator, especially for development of LAA asthma (12, 42, 62, 92, 103).
Many cross-sectional studies have shown significant correlations between skin prick
test positivity to a panel of common aeroallergens and LAA (22, 33, 67, 102, 103,
117), especially if the skin prick tests are positive to other fur animals, such as dog or
cat (46, 123).
Total IgE has been measured in a few studies, which have found an association
between elevated total IgE levels in serum and LAA (46, 99). However, the ongoing
4activation of the immune system because of LAA might influence skin prick test and
total IgE results. Therefore to ascertain to what extent these constitute predisposing
factors, prospective studies with pre-exposure tests are needed. In the two studies
found presenting pre-employment skin prick test data, atopy by this criterion was
indeed correlated with subsequent LAA development (16, 17); in one study, the
increased relative risk was between 4-8 after 1-3 years of exposure (17). Also, as
mentioned, atopics might develop symptoms earlier (16, 58) and are more likely to
progress to asthma than nonatopics (27, 74, 99).
Hereditory factors might predispose subjects to LAA. Indeed a few studies of genetic
markers have found HLA-linked (human leucocyte antigen) factors suggested to protect
from (HLA-B16) (101) or increase the risk for LAA (HLA-DR4) (79).
Other host factors have been shown to exert at most a mild influence over the risk to
develop LAA. Smoking has in some studies been shown to be a significant effect
modifier (25, 33, 118), but not in others (2, 12, 22, 46, 102). No significant
correlations have been found between gender and LAA (12, 33, 46).
Allergens from rats and mice
Personnel working with animals are exposed to animal urine, hair, dander, saliva and
blood, depending on the work. By sheer volume, urine is the most important potential
allergen source in laboratory rodents; a mature rat excretes 10-20 ml of urine/day. In an
average rat room with a few hundred animals, thus several litres of urine are being
produced per day, some of which will dry out and become airborne. Both rat and
mouse urine has been shown to contain high amounts of protein, especially in males,
and these proteins have been shown to constitute important allergens (39, 97).
The most important rat and mouse allergens are pheromone-binding proteins,
members of the lipocalin superfamily, a2u-globulins in rat and Mus m 1 isoallergens (or
MUPs, major urinary proteins) in mouse (19). These proteins are related, showing
66% sequence homology between rat and mouse (43). The bulk of these proteins are
synthesised in the liver and excreted in urine (63). Mature male rodents excrete up to
300-fold higher amounts than female rodents (64, 94, 116). Several studies describe
two cross-reacting proteins in rat urine with slightly different molecular weights in
SDS-PAGE, a2u-globulin (17 kd) and prealbumin (21 kd) (39). However, Bayard et al
(8) could show that these were in fact isoallergens. It has therefore recently been
proposed that they be termed Rat n 1.01 (prealbumin) and Rat n 1.02 (a2u-globulin)
(108). Half or more of the protein in male rat urine consists of these isoallergens. In the
mouse, the MUP complex comprises about 90% of the protein in the urine (73).
However, varieties of these rat and mouse isoallergens are also excreted by various
glands by both sexes, and can also be found in saliva (59, 95). Perhaps the allergen
termed Ag 3 or Mus m 2 and found in mouse hair (86), is a member of the MUP
complex. About 60-90% of rat allergic patients react to the a2u-globulin isoallergens,
and most mouse allergics react to the Mus m 1 complex (39, 49, 63, 91).
Albumin (68kd) is another allergen present in rat urine and serum to which about
30% of rat allergics react (37, 39, 120).
5Table 2. Sensitization and symptoms among laboratory animal workers (exposed to mostly rats
and/or mice).
Reference No.
subjects
%
sensitized
(spec
IgE)
%
symptomatic
Nasal/eye
symptoms,
% of
symptomatic
Chest
symptoms,
% of
symptomatic
Skin
symptoms,
% of
symptomatic
Lincoln et al
-74 (62)
238 - 11 81 48 56
Lutsky &
Neuman -75 (68)
1 293 - 15 100 71 58
Taylor et al
 -76 (113)
474 - 23 74 39 47
Cockcroft et al
-81 (22)
179 16 27 89 43 51
Davies &
McArdle -81
(26)
585 - 20 56 16 29
Newman Taylor
et al -81 (74)
145 - 19 85 41 15
Schumacher et al
-81 (92)
121
(mouse)
32 (SPT)
22 (EIA)
32 74 (nasal)
36 (eye)
13 41
Slovak & Hill
-81 (102)
146 15 30 67 32 -
Beeson et al
-83 (9)
69 - 22 67 20 13
Venables et al
-88 (117)
124 14 (SPT)
40
(RAST)
33 85 25 42
Aoyama et al
-92 (6)
5 641 ND 23 82 47 45
Cullinan et al
-94 (25)
238 10 31 71 32 48
Bryant et al
-95 (18)
130 62 56 100 (nasal)
63 (eye)
46 41
Fuortes et al
-96 (33)
103 19 (rat)
11
(mouse)
33 85 42 30
Hollander et al
-96, rat (46)
458 18 19 90 32 57
Hollander et al
-96, mouse (46)
377 10 10 90 32 42
SPT = skin prick test; RAST = radio-allergosorbent test; EIA = enzyme immunoassay
6Allergens from other laboratory animals
The main allergen from rabbit is present in saliva and fur, Ory c 1 (or Ag R1) (84); also
a rabbit immunoglobulin light chain has shown some allergenic potency (83). Among
work exposed, allergy to guinea pig is common (68). Four major allergens (to which
³50% patients have IgE), were found in guinea pig room dust, all of which were also
present in both dander, fur, saliva and urine (121). Urinary allergens were found to
dominate in air samples (111).
Measuring airborne allergens
Many methods have been devised to quantify levels of airborne allergens, for the
estimation of exposure and to evaluate ventilation improvements (1, 24, 28, 29, 35, 41,
49, 61, 81, 90, 110, 111, 112, 115). The values reported using these methods may
differ by several orders of magnitude for one and the same species. Although this might
reflect actual environmental differences to some extent, these methods differ in many
ways, most of which are likely to influence the allergen values;
Sampling and elution: - Pumps for air sampling, air flow, filter holders
- Filter types, e g fibre glass, polycarbonate or 
polytetraflouroethylene, and pore sizes
- Methods to elute allergens from the filters, e g shaking or 
homogenisation, use of Tween 20 or not
Immunological analysis: - Assay set-up, e g inhibition or sandwich assay
- Source of detection antibodies, patient serum, polyclonal,
or monoclonal antibodies
- Specificity, measuring one or several antigens 
- Visualisation method, e g radioactive, fluorometric, 
or enzymatic
Although sampling and elution methods have been compared in a few papers (1, 38),
only one presents a comparison between different immunological assays (112). In order
to be able to compare values derived from different studies or laboratories, and certainly
before any exposure limits can be proposed, a thorough standardization of methods
must take place.
However, conclusions drawn from studies with allergen measurements can often be
generalised. For instance that increasing air changes or reducing stock density in rat
rooms (29, 36) or housing rodents in ventilated cages will diminish allergen levels (41),
or that certain tasks expose workers to higher levels of aeroallergen than others (75).
The role of exposure for development of LAA
In several studies exposure as a risk factor has been assessed. Exposure variables
defined according to job title, numbers of years employed, hours of work with
rodents/week or by measured allergen load have been used. Exposure intensity defined
by job title or exposure years, have not been proven to be related to LAA (2, 6, 12).
Indeed, some have found an inverse relationship between exposure intensity by job title
or degree and LAA (62, 117), possibly because of healthy worker selection. Hours of
exposure/week has been shown to correlate significantly with LAA in some studies (6,
12), but not in others (22, 92).
7Using allergen measurement methods to estimate aeroallergen load can provide
further and more detailed information on exposure-response relationships. In a study by
Cullinan et al, full-shift personal samples were collected and allergen measurement
results distinguished between exposure categories. However, only a connection with
skin symptoms was shown; neither upper nor lower airway symptoms correlated to the
aeroallergen levels (25). In another study (54), tasks were assigned values and
weighted, and exposure intensity was found to significantly correlate with LAA
prevalence, although atopy gave a better correlation with LAA. In another recently
published study, Hollander et al found no exposure-response relationships in the whole
group of exposed workers. However, when subjects exposed <4 years were analyzed,
strong dose-response relationships were found to time-multiplied exposure if combined
with evidence of atopy (48).
Aims of the thesis
There were two major aims for this thesis:
1. To study the development of symptoms and sensitization against laboratory
animals, and assess host and exposure related risk factors with particular emphasis on
work in relatively clean environments.
2. To develop sensitive methods to quantify airborne rodent allergens and compare
these methods with those developed in other laboratories.
8Materials and Methods
All studies were approved of by the local ethical committees. All subjects gave their
informed consent to participation and received information on their personal test results.
The subjects from the university cohort were also given lectures on laboratory animal
allergy and on prevention and management. This chapter presents an outline of the
studies and methods. Detailed descriptions of methods are provided in papers I-VII.
Prospective study (I, II) and cross-sectional study (III)
Prospective study aims and design (I, II)
A prospective study was designed in which laboratory technicians were examined with
regard to lung function and immunology during their education. Those who according
to a postal follow-up questionnaire had subsequently worked as laboratory technicians
and were exposed to laboratory animals were re-examined two years after work start
together with matched unexposed referents (figure 1).
Those who had graduated and worked as technicians did not differ in allergy, atopy,
lung function etc. from those who had not. Thirteen subjects were excluded: they had
been only sporadically exposed at work or had one of these animals at home. Work
exposure to dog or cat was disregarded, as a majority had been exposed to one or the
other at home, often for a long time prior to the investigation.
To study selection to animal work, the pre-exposure values from all 43 laboratory
animal workers were compared to those of the 112 unexposed.
To study potential risk factors and their role in the development of sensitization and
symptoms against the animals, all exposed subjects were invited for a follow-up, and
were examined with the same tests and equipment as prior to exposure.
To compare symptom development among laboratory technicians with and without
animal exposure, non-exposed subjects were matched with exposed on 1) pre-exposure
atopy (skin prick test and/or Phadiatop positivity), 2) smoking/non-smoking, 3) age, 4)
gender.
Cross-sectional study aims and design (III)
Subjects (n=80, 21-53 years old, 68% women) who had worked ³5 months with rats
and/or mice in research departments at a university (n=48) and from the prospective
study cohort (n=32), were included in a cross-sectional study. Subjects with a rodent at
home were excluded from the study. The aims were to assess the possibility to avoid
development of allergy and sensitization to animals by working in a clean environment,
and to study potential risk factors (both host related and environmental) in a study
group with longer exposure time. Air samples were collected in order to assess
aeroallergen levels in research departments compared to animal house levels.
9                           225 students from 5 laboratory technician training schools assessed
 during first year  (questionnaire, SPT, Phadiatop, total IgE, lung function)
    168 (75%) graduated and  51 (23%) left school  6 (3%) not reached
      worked ³6 months as technicians     or worked <6 mo.      for follow-up
           43 technicians worked   13 were exposed        112 were
       with lab. animals ³5 months       sporadically       unexposed
   38 (88%) were    1 was excluded   4 unable or unwilling      36 matched
     followed up  (no available tests)     to participate  referents followed up
Figure 1. Study design of the prospective study.
Questionnaires (I-III)
All subjects answered extensive questionnaires on allergy in the family, personal
allergic and medical history, exposure to irritants, smoking habits and animal contact.
In the postal follow-up questionnaire sent to laboratory technicians, subjects answered
whether they had graduated, worked as technicians etc. Laboratory animal exposed
subjects also answered a questionnaire on extent of animal exposure, sex of the animals
used, protective measures etc.
Lung function, methacholine provocation (I, II)
Spirometry was performed with a wedge spirometer (Vitalograph, Buckingham, UK) at
least 20 minutes prior to the bronchial provocation. The highest value of three forced
expirations was chosen as FEV1 (forced expiratory volume during 1 second) and the
highest of three forced and three slow maximal expirations as VC (vital capacity) for
each patient.
Bronchial provocation was performed by inhalation of increasing concentrations of
methacholine (0.5, 2, 8, and 32 mg/ml). The nebulisate passed through a drying device
before inhalation to achieve maximum deposition in the lungs (69). The test was
stopped at an FEV1 decrease of ³20% compared to the value measured after inhalation
of diluent, or after inhalation of the highest concentration. The cumulative methacholine
dose which caused a 20% decrease in FEV1 was calculated by interpolation on a log
cumulative dose scale (PD20). In cases where FEV1 did not decrease by >20% at the
highest concentration, PD20 was assigned a value of >10 mg. The average percent
decrease in per mg of inhaled methacholine (cumulative dose, linear scale; "slope") was
calculated by linear regression (23, 76).
Skin prick tests (I, II)
Extracts from eight common aeroallergens were tested on the volar aspects of both
forearms: birch, timothy, mugwort, dog, cat, two types of moulds (Alternaria and
Cladosporium) and house dust mite (Dermatophagoides pteronyssinus). Histamine di-
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hydrochloride, 10 mg/ml, was used as a positive reference and dilution solution as
negative control. Reactions ³2 mm in diameter larger than the negative control were
considered positive. A weal size equal to the histamine weal was defined as +++ in
accordance with Agrup et al (2). A person with at least one +++-reaction or two ++
(weal area=half of histamine weal area) reactions was defined as atopic. Sensitivity to
laboratory animals was determined by skin prick tests using hair extracts from guinea
pig, mouse, rat, rabbit and hamster (1:20 w/v, ALK, Copenhagen, Denmark).
Serum tests (I-III)
Phadiatop and total-IgE Sera were stored at -70°C until analyzed. Total-IgE was
analyzed using an in-house ELISA (Enzyme Linked Immuno-Sorbent Assay) using
alkaline phosphatase conjugated rabbit anti-IgE antibodies for detection (I and II).
Phadiatop analysis (Pharmacia) (I-III) and total IgE (III) was performed at the
accredited Department of Clinical Immunology, Karolinska Hospital.
Specific IgE against laboratory animals Post-exposure sera from laboratory
technicians and university cohort sera were tested for IgE against rat urinary proteins
and Mus m 1, respectively, using in-house ELISAs. Sera from laboratory technicians
exposed to other species were tested with Phadebas RAST (by Pharmacia, Uppsala),
for specific IgE against these animals (rabbit, hamster, horse, pig and chicken).
Methods to measure rat and mouse urinary aeroallergens (III, IV)
To enable quantification of airborne allergens from rats and mice in different
environments, for the evaluation of ventilation solutions and subject exposure, sensitive
methods were developed.
Filter sampling and elution
Air samples were collected at 2 l/min air flow using 25 mm filters (different types were
tested) in IOM filter cassettes (SKC Inc. Valley View, Pa. USA). Filters were eluted
within hours of sampling in 1 ml PBS, 0.5% Tween 20, 0.15% Kathon (Rohmand
Haas, Hydrosupra Kemiservice AB, Helsingborg, Sweden) during rotation for 1 hour.
The filters were discarded and the eluates stored at -20ûC until analysis.
Quantification of rat urinary allergen
Two murine monoclonal antibodies (MAbs) against rat urinary allergen were developed
using hybridoma techniques (34) (Mabtech AB, Stockholm, Sweden). Epitope map
analysis was performed using a BIAcore Biosensor (53) (Pharmacia, Uppsala,
Sweden). Specificity of MAb(1) and Mab(6), respectively, was determined using
Western blot analysis. ELISA was used to study binding to purified Rat n 1
isoallergens prealbumin and a2u-globulin.
A Rat n 1 standard extract was prepared from male post-pubertal Sprague-Dawley
(S-D) rat urine, which was concentrated and dialyzed (12-14 kd cut-off), and thereafter
affinity purified using Mab(6). A sandwich ELISA was developed in two versions as
shown in figure 2, with standard or amplified sensitivity.
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To achieve amplification, a novel compound, N-biotinyl-4-hydroxybenzohydrazone
(or BHBH) was synthesized (by Per Larsson) and used according to the CARD
(catalyzed reported deposition) concept (13).
Specificity of the assay was assessed by studying binding to a number of proteins
derived from both rodents (S-D and Wistar urine, purified rat serum albumin, fur
extract, rat room dust) and other animals (Mus m 1, mouse urine, mouse serum, guinea
pig urine, or sera from rabbit, cat, dog or horse).
Quantification of mouse urinary allergen
Urine from post-pubertal male NMRI mice was concentrated, and the proteins were size
separated through FPLC gel filtration on Superose 12 columns (Pharmacia). Fractions
from the protein peak (Mus m 1) were collected and freeze dried. New Zealand White
rabbits were immunized according to Hudson and Hay (50) and boostered twice. The
rabbit serum was Na2SO4 precipitated for IgG enrichment and thereafter dialyzed, after
which the antibodies were affinity purified using Mus m 1.
Antibody specificity tests were performed on a panel of antigens (mouse serum, rat
urine and serum, guinea pig urine, serum and IgG, sheep serum and IgE, sera from
goat, cat and cattle, IgG from pig, horse, dog and monkey, and human urine and
serum).
A polyclonal Ab sandwich ELISA against Mus m 1 was developed, similar to the
standard RUA assay (figure 2). Microtiter plates were coated with rabbit antibodies
over night. After washing, Mus m 1 (50-1500 pg/ml) and filter eluates diluted at least
twofold were added to the plates and incubated. Bound antigen was detected with
biotinylated anti-Mus m 1 followed by streptavidin-horse radish peroxidase incubation,
and visualised with TM-Blue (soluble form, TSI-CDP, Milford, MA, USA). The
colour reaction was stopped with 1M H2SO4 and read at 450 nm, and background
absorbance at 650 nm was subtracted.
Step Standard RUA assay Time Step Amplified RUA assay Time
 1. Coating with capture antibody over 
night
1. Coating with capture antibody
 MAb(6) in PBS  MAb(6) in PBS
2. Post-coating with 1% BSA 60 min
2. Incubation with standard 90 min 3. Incubation with standard 90 min
and sample eluate and sample eluate
3. Incubation with biotinylated 60 min 4. Incubation with biotinylated 60 min
detection Ab, MAb(6) detection Ab, MAb(6)
4. Incubation with straptavidin- 60 min 5. Incubation with straptavidin- 30 min
horseradish peroxidase horseradish peroxidase
6. Incubation with amplifier 15 min
7. Incubation with straptavidin- 30 min
horseradish peroxidase
5. Incubation with substrate 15 min 8. Incubation with substrate 15 min
6. Colour development stopped 9. Colour development stopped
7. Plate read at 450 nm 10. Plate read at 450 nm
over 
night
Figure 2. Schematic description of the RUA assay. In the standard version, the plates are
washed 3 x prior to the incubations, which were carried out at 37ûC (until step 5). In the
amplified version, the plates are washed 4 x prior to the incubations, which were carried
out at room temperature.
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Comparison of methods to measure rodent aeroallergens (V-VII)
Comparison of a RAST inhibition method and a monoclonal ELISA
assay, aims and study design (V)
This study was initiated as we noted that airborne RUA sample values differed greatly
between those measured in another laboratory (National Heart and Lund Institute, UK)
and in our laboratory (National Institute for Working Life, Sweden). To investigate
whether this was due to actual differences in the occupational environment or was a
result of methodological differences, 40 samples (15 in the UK, and 25 in Sweden)
were collected in animal facilities containing mainly rats. The samples were eluted and
aliquoted for analysis in each laboratory. Thus each laboratory analyzed all 40 samples
by its own method, the RAST inhibition method (see table 3 and Gordon et al (36)) and
the unamplified monoclonal sandwich ELISA, respectively.
Investigation of some sources of assay variation (V)
Since sample values are interpolated from a standard curve, the binding of the standard
extracts in the assays will influence the resulting sample values. To assess the
immunological similarity of the standards (derived from Wistar rats in the UK assay,
and from S-D rats in Sweden), they were assayed in serial dilutions in parallel with
each laboratoryÕs own standard extract.
Also, the albumin content of the samples was estimated (by RAST inhibition)
because
1) the Swedish rats were on average older than the UK rats in the rooms in which
samples were collected (and rats excrete increasing amounts of albumin with age (39)),
which could increase the proportion of airborne albumin, and
2) should albumin be present it would be detected in the RAST inhibition assay, but
not in the monoclonal assay, contributing to the differences in values.
Comparison of methods to assess airborne RUA and MUA levels, aims
and study design (VI, VII)
In a European Concerted Action programme (ÒEpidemiology of occupational allergic
asthma and exposure to bio-aerosolsÓ), the need for comparison and evaluation of
current methods to measure aeroallergens was recognized. The ultimate objective was to
give an informed recommendation for future aeroallergen measurement, and
standardization of methods. Thus a three-country study was designed, in which air
samples were taken in triplicate in three countries, were divided among the participants
and then eluted and analyzed by the rat and mouse urinary allergen measurement
methods of each participating laboratory, as shown in figure 3.
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Factors influencing RUA and MUA antigen detection, aims and study
design (VII)
In the air filter analysis we noted a large variation in nominal allergen levels between the
methods, the greatest being between RUA RAST inhibition and sandwich EIAs.
Further investigations were performed in order to evaluate the relative importance of
assay set-up, antibody specificities, standard extracts and antigen decay, on the abilities
of the assays to detect antigen. Thus the following studies were performed:
1) The quantification of protein concentrations of the respective assay standard
extracts will ultimately determine the value of the air samples. As we also wished to
perform the following studies in all three institutes using the same protein
concentrations, the extracts were distributed and protein quantified according to the
methods of each institute.
2) The importance of the assay set-up (inhibition or sandwich) was assayed using
identical standard extract and antibodies, and analysing 25 air samples for RUA.
3) To compare the RUA and MUA standard extracts, and study the specificitites of
the antibodies to these and to rat and mouse room dust samples, Western blotting was
performed.
4) To compare the antigen detection of the respective RUA and MUA assays, all
standard extracts, rat and mouse room dust extracts, an animal food extract and dust
from a home with cats and a home without cats, were assayed.
5) To study the influence of antigen decay, RUA and MUA were subjected to an
accelerated degradation protocol and analyzed in parallel to fresh antigen in serial
dilutions in all assays.
RUA,  MUA method of National Heart
and Lung
Institute, London
(NHLI)
Wageningen
Agricultural
University
(WAU)
National
Institute of
Working Life,
Solna (NIWL)
samples taken in
(total 222 samples)
the UK
n = 42 (3 * 14)
the Netherlands
n = 105
(3 * 35)
Sweden
n = 75 (3 * 25)
elution and analysis
on RUA and MUA
74 samples
18 blank filters
74 samples
18 blank filters
74 samples
18 blank filters
second analysis of WAU
and NIWL extracts
74 samples 74 samples
Figure 3. Study design for comparison between RUA and MUA air sample values
measured in three laboratories. Submitted.
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Statistics (I- VII)
Calculations and statistical analysis were performed using Microsoft¨ Excel (Microsoft
Corp, Redmond, WA, USA) and Statview¨ (Abacus Concepts, Berkeley, CA, USA),
with the addition of EpiInfo, version 5 (USD Inc, Stone Mountain, GA, USA) (in
paper III) or Minitab (Minitab Inc, State College, PA, USA) software (in paper IV). In
paper VI, SAS (version 6.09; SAS Institute, Cary. NC; USA) was used.
For variables with skewed distribution, significance was tested with the non-
parametric Wilcoxon signed rank test, Kruskal-Wallis or Mann-Whitney U-test as
appropriate, otherwise StudentÕs t-test. Discrete variables were tested with c2-test (or
FisherÕs exact test). Skewed continuous variables are presented as median values (with
25th to 75th percentiles or range) or geometric mean, and normally distributed variables
with mean value. To study correlation and agreement between methods, linear
regression and Bland-Altman (11) plot analysis was performed. In addition, 95%
confidence intervals were calculated in papers III and VI. A P-value <0.05 was
considered significant.
Results
Prospective study (I, II)
Comparison between exposed and matched non-exposed subjects
The prevalence of atopy and allergic symptoms had increased in both the exposed and
unexposed groups at follow-up. The increase in reported asthma symptoms among
exposed was statistically significant (from 1 person to 7, P<0.05). At follow-up, FEV1
had decreased significantly, by an average 28 ml/year and VC by 12 ml/ year (P<0.01,
paired t-test, combined groups). There were no significant differences between the
groups in any of the tested allergy or lung function variables at follow-up.
Thus, in two matched groups of subjects with the same profession, exposure to
laboratory animals per se  did not elicit significant differences between the exposed/non-
exposed groups during the follow-up time.
16
Sensitization and symptom development
Forty-three subjects had worked with laboratory animals ³5 months at follow-up and
were invited to participate. One 23 year-old female was investigated, but was
subsequently excluded from the analyses, since objective tests for sensitization against
the animal to which she was exposed (vole) were not available 1. Two declined to
participate, one had moved abroad and changed profession, and one could not
participate for medical reasons.
All of the remaining 38 exposed subjects who participated in the follow-up were SPT
negative to the laboratory animal hair extracts prior to employment. After a median
laboratory animal exposure time of 18 months (mean 19 months, range 5-33), seven
had developed a positive SPT against one or more of these extracts. Among the 30
technicians exposed to rats, six were skin prick test positive against rat (20%), and
among the 23 exposed to mice, two were positive against mouse. Four SPT positive
subjects were found to have measurable specific IgE in serum against rat and/or mouse
urinary allergens. All RAST tests to other animals to which subjects were work
exposed, were negative.
Six the 7 laboratory rodent sensitized, and another 2 subjects (altogether 8/38)
reported at least one allergic symptom related to laboratory rodent exposure. Six had
experienced nasal symptoms, 5 eye, 3 chest and 4 had skin symptoms. One SPT
positive subject had rhinitis but was uncertain of the relationship to animal work. Most
symptoms were mild. Of the three who reported chest symptoms (wheezing, tightness
of the chest or coughing) during animal work, one had developed physician diagnosed
laboratory animal asthma. The other two had not sought medical help.
The subject with the most hyperresponsive airways had experienced wheezing, but
reported only urticaria at laboratory animal contact. She kept a laboratory rat at home as
a pet and had high levels of rat specific serum IgE. She was subsequently put on
asthma medication.
To summarise, 9/38 (24%) had developed animal work related symptoms (n=8),
and/or specific IgE to the animals (n=7). The incidence of symptoms and sensitization
was thus 13 and 12, respectively, in 100 person years in the first average 19 months of
exposure.
Lung function and bronchial responsiveness
FEV1 and VC values did not differ between the nine subjects with sensitization and/or
symptoms against laboratory animals and the 29 subjects without, neither before first
exposure, nor at follow-up. Neither was there any difference between the groups
regarding change in FEV1 or VC from before first exposure to follow-up.
                                                
1Prior to exposure, she was non-atopic by both SPT (skin prick test) and Phadiatop, had
no allergic symptoms, had an elevated total IgE level, and a PD20 value of 2.88 mg. After
8 months of 20 hours/month exposure in animal confinement facilities, she reported eye
and nose symptoms, but only at contact with vole. She had developed a 3+ SPT reaction
to birch pollen, yet Phadiatop remained negative, and her total IgE was elevated. The
PD20 value was 0.53 mg.
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Figure 4. Slope values (% change in FEV1 per mg methacholine (cumulative dose)
before employment and after follow-up in 38 laboratory animal exposed subjects.
Modified from Renstrm et al, Eur Resp J 1995; 8: 1514-1519, European Respiratory
Society Journals Ltd.
There were no differences before exposure between those who developed
sensitization and/or symptoms against the animals and those who did not, with regard
to bronchial responsiveness. However, at follow-up, sensitized/symptomatic subjects
had significantly more reactive airways (PD20 or slope) than non-reactive subjects
(P<0.05).
The sensitized/symptomatic subjects had lower PD values (P<0.01) and a steeper
slope (P<0.01, figure 4) at follow up than before first exposure. Six of the 9 had a
more than 3-fold increase in bronchial responsiveness.Bronchial responsiveness among
non-LAA subjects was by average unchanged.
Thus early LAA was associated with increased bronchial responsiveness in most
subjects. The level of pre-employment bronchial responsiveness did not influence the
magnitude of change in responsiveness.
Predisposing factors for sensitization and symptoms
Several potential risk factors from the investigation prior to exposure were compared
between the seven subsequently sensitized and the 31 non-sensitized. Neither pre-
exposure SPT or Phadiatop positivity, total IgE, allergic symptoms, allergy in the
family, smoking, exposure to fur pets, or lung function data were significantly different
between sensitized/non-sensitized.
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There was a tendency of association between some indicators and subsequent
sensitization, for instance total IgE (p=0.09, Mann-Whitney U-test). Total IgE was
however significantly higher before exposure among the eight who developed
symptoms against the laboratory animals compared to the 30 non-symptomatics, see
figure 5. Of those who reported symptoms or were sensitized against laboratory
animals, 7 out of 9 had pre-exposure total-IgE >100 kU/l. Among non-LAA subjects
the number was 8 of 29 (P<0.01); relative risk for those with elevated total IgE was 5.4
(95% confidence interval 1.3-22). Paper II erroneously states other values (page 1518,
second paragraph), which however does not influence the conclusions.
Positive predictive values were calculated (4) for development of symptoms. The
positive predictive value (4, 103)was 0.44 for total IgE >100 kU/l for development of
symptoms. For development of sensitization, the predictive values were 0.33 for total-
IgE and 0.40 for previous rhinitis/conjunctivitis. The predictive value of family allergy
was 0.17.
Table 4. Potential exposure risk or prevention factors for matched rat and/or mouse
exposed sensitized/symptomatic (ÒLAAÓ) and non-LAA subjects.
Risk/prevention
factor
LAA
 n=9
Matched
non-LAA, n=9
Significance
P -value
Exposure, months 18 (15.5-25)# 22 (15-24) N S
Exposure, hours per
month
80 (20-160) 9 (4-36) <0.05
³60% male rodents 8 1Û <0.01
Gloves often/always 5 6Û N S
Mask often/always 2 1Û N S
Use of vent. bench 3 4Û N S
Organic solvent
exposure
5 3 N S
# median (25th-75th percentile)     N S not significant     Û n=8, due to missing answers
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Exposure as a risk factor for sensitization and symptoms
The laboratory animal workers who developed sensitization or symptoms ÒLAAÓ (n=9)
were not exposed for more months than those who did not (n=29). However, they had
been exposed for more hours/month (median 80 and 18, respectively, P<0.05). Almost
all sensitized/symptomatic subjects had an elevated total-IgE.
However, we wished to study potential exposure risk or protective factors per se,
therefore the 9 were matched with non-LAA subjects with regards to pre-exposure
smoking and elevated total IgE and/or positive Phadiatop.
Although this was a small study, we found that sensitized/symptomatic subjects
worked for significantly more hours/month, and mostly with male rodents, see table 4.
These factors were also associated (P<0.01). However, we can not exclude that factors
not significant in this study, might be shown to be of importance in a larger study.
In the cohort of 38 laboratory animal exposed, 7 subjects had a combination of elevated
pre-employment total IgE and exposure to mainly male rodents for more than 20
hrs/month. Of these, 6 had developed sensitization and/or symptoms, compared to none
of the 8 with neither risk factor.
The results of the prospective study might be phrased thus: in workers newly
exposed to laboratory animals, total IgE increased the risk to develop
sensitization/symptoms; in combination with high exposure (many hours work with
male rodents), most subjects were sensitized and/or symptomatic.
Selection
The 155 (139 women) laboratory technicians had at pre-exposure a median age of 21
(range 18-51) years. No significant differences are found between the prevalence of
different indicators of allergic disposition among those who subsequently worked with
laboratory animals (n=43) and those who did not (n=112). However, there was a
tendency towards lower prevalence of positive SPT against common allergens among
subsequently exposed compared to non-exposed subjects (21% vs 37%, P=0.06).
Cross-sectional study (III)
Subjects, and sensitization and symptoms to laboratory rodents
Of the 80 subjects (university staff subjects, n=48, and laboratory technician cohort,
n=32), 70 had worked with rats an average 6.8 years (median 2.4 years) and 44 with
mice for an average 5.8 years (median 1.9). All subjects worked with animals only in
research department laboratories. Among the rat exposed subjects, 16 (23%) were
sensitized to rat urine (spec IgE ³0.2 kU/l). Of the mouse exposed, 5 (11%) were
sensitized to mouse urine. Sensitization to one rodent was significantly related to
sensitization to the other (P <0.0001), even without exposure to the other. Since there
seemed to be immunological cross-reactivity between the species, rat and mouse
exposure, sensitization or symptoms were pooled in some analyses.
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Symptoms to rats were reported by 22 (31%) of rat exposed and symptoms to mice
by 9 (20%) of mouse exposed. Sensitization to the rodents was significantly associated
with expression of LAA symptoms (P<0.0001).
Aeroallergen measurements
The sample eluate detection limit for the amplified RUA assay (twofold diluted samples)
was 40 pg/ml. For air filter eluates with undetectable RUA levels, the mean detection
limit was 0.26 ng/m
3
. Samples were collected in the animal facility for comparison with
research department levels. RUA levels in personal animal work samples from the
animal house (median (range) 1.5 (<0.26 - 5.3) ng/m
3
, n=11) were higher than the
personal animal work samples in the research departments (<0.26 (<0.26-0.52) ng/m
3
,
n=7), P=0.01. Also static samples were significantly higher in the animal house (0.25
(<0.26 - 13) ng/m
3
, n=26) than in the research departments (<0.26 (<0.26 - 0.32)
ng/m
3
, n=19), P<0.001. The detection limit for the MUA assay was 0.1 ng/ml (two-
fold diluted samples). For air filter samples with undetectable MUA levels, the mean
detection limit was 0.8 ng/m
3
. The differences between MUA levels in the animal house
(median (range) <0.8 (<0.8 - 26) ng/m
3
, n=21) and research department (<0.8 (<0.8 -
1.1) ng/m
3
, n=13) did not reach statistical significance.
Thus the rodent aeroallergen levels in the research departments were very low, and
few research department samples were measurable.
Sensitization and symptoms at low exposure
The possibility to avoid sensitization was studied among staff with £4 years exposure,
working in research department laboratories with special ventilation solutions, such as
ventilated benches or cabinets (26 of totally 48 with £4 years rodent exposure). Three
subjects had developed specific IgE to rats: all 3 had worked with mostly or exclusively
male rodents and had a total IgE ³100kU/l and/or a positive Phadiatop test. Two were
from the prospective study, and were skin prick test negative to rodents prior to first
exposure. Six of the 26 reported symptoms to rodents - all worked with ³60 % male
rodents and/or ³10 hours/week and/or had a total IgE ³100kU/l and/or a positive
Phadiatop test.
Sensitization and symptoms were studied in research department subjects with long
exposure who presently worked with rodents using ventilated cabinets or benches (24
of totally 32 exposed >4 years). Of these, 10 (42%) had specific IgE to rodents, some
with very high levels. Twelve had experienced symptoms during animal work. Ten
subjects with >4 years rodent exposure reported to have been rodent positive by skin
prick test or RAST prior to this study, some more than a decade previously. Eight of
these were found to be have rodent specific IgE in our tests, 7 of whom worked with
ventilated benches.
Those with >4 years of exposure worked significantly more with male rodents (75%
vs 48%, P<0.05), but not more hours/week with either rats or mice, than subjects
exposed £4 years. Furthermore, a higher proportion was symptomatic (50% vs 21%,
P<0.01) and sensitized (39% vs 10%, P<0.01) against the animals.
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Table 5. Risk factors for sensitization (specific IgE ³0.2 kU/l to rat and/or mouse urine) and
allergic symptoms when working with laboratory rodents.
Sensitized   Û Symptomatic
Risk factor N and (%)
sensitized
without
risk factor
N and (%)
sensitized
with risk
factor
  Preva-
lence
Rate
Ratio
95%
Confidence
Interval
N and (%)
symptomatic
without
risk factor
N and (%)
symptomatic
with risk
factor
Preva-
lence
Rate
Ratio
95%
Confidence
Interval
Smoking 16/63 (25)  3/16 (19) 0.74 0.24-2.2 20/64 (31) 6/16 (38) 1.2 0.58-2.5
Total IgE
>100 kU/l#
7/59 (12) 10/20 (50) 4.2 1.8-9.6 13/59 (22) 12/20 (60) 2.7 1.5-5.0
Posi t ive
Phadiatop#
8/58 (14)  9/21 (43) 3.3 1.5-7.3 13/58 (22) 12/21 (57) 2.6 1.4-4.7
Total IgE
>100 or pos
Phadiatop #
4/48 (8.3) 13/31 (42) 5.0 1.8-14 8/48 (17) 17/31 (55) 3.3 1.6-6.7
Allergy in
parents/
siblingsÛ
7/47 (15) 10/31 (32) 2.2 0.92-5.1 14/48 (29) 11/31 (35) 1.2 0.64-2.3
Allergy to
pollen/dustÛ
9/61 (15)  8/18 (44) 3.0 1.4-6.7 17/62 (27) 9/18 (50) 1.8 0.99-3.4
Allergy to
other
animalsÛ
8/65 (12)  9/14 (64) 5.2 2.4-11 17/66 (26) 9/14 (64) 2.5 1.4-4.4
Exposure
³10 h/weekÛ
10/49 (20)  6/27 (22) 1.1 0.44-2.7 12/49 (24) 13/28 (46) 1.9 1.0-3.6
³60% male
rodentsÛ
3/30 (10) 13/44 (30) 3.0 0.92-9.5 5/30 (17) 21/45 (47) 2.8 1.2-6.6
No use of
glovesÛ
8/31 (26)  9/43 (21) 0.81 0.35-1.9 10/31 (32) 16/44 (36) 1.1 0.59-2.1
No ventilated
benchÛ
13/50 (26)  4/25 (16) 0.62 0.22-1.7 18/50 (36) 8/26 (31) 0.85 0.43-1.7
# = 1 missing blood sample
Û = 1 or more subjects have answered ÒdonÕt knowÓ or not answered question
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Figure 6. Elevated total IgE and/or positive Phadiatop (ÒatopyÓ) combined with working
with ³60% male rodents as risk factors for sensitization and symptoms against laboratory
rodents.
Relationship between atopy, exposure and sensitization
We found significantly more subjects who were sensitized or had experienced
symptoms among those who were Phadiatop positive, or had an elevated total IgE or
were allergic to other fur animals, but not for those with allergy in the family (table 5).
Those working with mainly male rodents (³ 60% male animals), had a higher symptom
prevalence rate. However, working ³10h/week was not significantly associated with
rodent sensitization. Working ³10 h/week and with male rodents was correlated
(P<0.01). Research department personnel with a combination of elevated total IgE and
working with male rodents had an 11-fold increased prevalence of sensitization and 6-
fold increased prevalence of symptoms compared to subjects with neither risk factor
(figure 6). All 7 subjects with a combination of elevated total IgE and/or positive
Phadiatop, allergy to other fur animals and >60% male rodent exposure were
sensitized, whereas only 1/21 with neither risk factor was sensitized. Use of gloves
and/or ventilated benches were not, however, significantly associated with lower
sensitization or symptom prevalence (table 5).
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Aeroallergen measurement methods (III, IV)
Monoclonal RUA sandwich ELISA and measurements in a refurbished
rat room (IV)
The properties of the monoclonal antibodies are presented in table 6. The MAbs were
shown to be highly specific, and did not react to proteins from mouse urine (although
they are 66% homologous (43)), nor to any of the other tested extracts derived from
other than rats. The MAbs did recognise urinary antigens from other rat strains, and
detected antigens in other rat extracts, such as rat room dust.
The detection limit for the sample eluates (diluted twofold) was 10 pg/ml, or 0.08
ng/m3 for 1-hour samples collected at 2 l/min. In the unamplified assay, the detection
limit was ten-fold higher, 0.1 ng/ml.
Samples were collected in a refurbished rat room in which a perspex screen had been
installed, behind which were the cage racks. This had pores through which air was
drawn to the outlet behind the screens. When the screens were closed, the RUA levels
were very low, median 0.2 ng/m3 (similar to corridor levels), significantly lower than if
the screens were open (0.9 ng/m3), or behind the screens (0.9 ng/m3). During cage
changing or cleaning the levels were however high (18 ng/m3).
Polyclonal MUA sandwich ELISA (III)
The properties of the polyclonal antibodies and the MUA sandwich ELISA are
summarized in table 6. Native SDS-PAGE showed that the standard consisted of Mus
m 1, showing one strong band at 19 kd, and isoelectric focusing showed a group of
proteins with pI values between 4.2 - 4.6. Antibody specificity tests showed strong
binding to mouse serum (which contains Mus m 1), very weak binding to goat and
sheep serum, and none to the other antigens.
The detection limit for the sample eluates (diluted twofold) was 0.1 ng/ml, or 0.8
ng/m3 for 1-hour samples collected at 2 l/min.
Table 6. Properties of the murine monoclonal antibodies developed for use in the
sandwich ELISA assay against RUA.
MAb(6) MAb(1)
Isotype IgG1 IgG1
Specificity Rat n 1.02
Rat n 1.01
Rat n 1.02
Rat n 1.01 weak
Ab affinity constant
to rat urinary protein
5.3 x 109 2.6 x 109
Epitope Unique, present on Rat n 1
isoallergens
Unique (other), on Rat n 1
isoallergens
RUA sandwich ELISA role ÓcaptureÓ Ab ÓdetectionÓ Ab
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Figure 7. Comparison of RUA values obtained between the in-house amplification
method (BHBH) and a commercial amplification method (AMPAK, Dakopatts).
Comparison between some different filters
Values obtained using different filters were tested in parallel samples (i e collected with
pumps placed 15 cm apart). RUA or MUA values were found to correlate between 0.8
mm polycarbonate (PC) and polytetraflouroethylene (PTFE) filters: the median ratio
PC/PTFE was 1.1, r2=0.69 (n=15 pairs). PC filters were also compared with 0.3 mm
Gortec filters (n=9 pairs) (Quan-tec-air Inc, Rochester, MN, USA) and although the
values correlated well (r2=0.98), Gortec RUA values were a median 1.9-fold higher.
Different pore sizes of PTFE filters (0.5 and 1.0 mm, n=11 pairs) were compared; the
median ratio between values obtained with 0.5 mm to 1.0 mm filters was 1.0 and the
values correlated (r2=0.90).
Comparison between values obtained using the in-house and a
commercial signal amplification system
To compare the values obtained using the developed amplification system (BHBH),
with values using a commercially available method, AMPAK (Dakopatts, lvsj,
Sweden) (93), RUA concentrations were determined using both in 23 sample eluates.
The values obtained were very similar, r2=0.99, figure 7. However, in samples with
high concentrations, the in-house method appears to be inhibited, resulting in low OD
values. For this reason, and to avoid the need for dilution series to save reagent,
samples are routinely first run in the unamplified method.
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Figure 8. Nominal aeroallergen values using RAST inhibition and MAb sandwich ELISA,
respectively. Modified from Clin Exp Allergy 1997; 27: 1314-1321, Blackwell Science
Ltd.
Comparisons of methods to measure RUA and MUA (V-VII)
Comparison between RAST inhibition and monoclonal sandwich ELISA
for RUA measurement (V)
Log RUA values obtained using RAST inhibition and MAb ELISA, respectively, were
correlated (r2=0.72, p<0.0001). However, the RAST inhibition values were several
and varying orders of magnitude higher than the ELISA values; median (range) ratio
RAST/ELISA for 37 eluates with measurable RUA levels, was 316 (7 - 2676). RAST
inhibiton median (range) values were 9670 (21.6 - 384 000) ng/m3 and ELISA median
(range) values 22.2 (<0.8 - 861) ng/m3 for all 40 samples.
Moreover, comparing samples collected in Sweden with samples collected in similar
situations in the UK, the Swedish samples contained higher levels of RUA, if analyzed
by RAST inhibition (median Swedish samples 31 700 ng/m3, median UK samples 333
ng/m3, p=0.01), but similar levels according to the monoclonal sandwich ELISA
(median Swedish samples 27.1 ng/m3, median UK samples 12.9 ng/m3).
Albumin quantification of the sample eluates showed that RUA and albumin content
were associated. However, in the samples with high albumin content, the RAST
inhibition and the ELISA values were not correlated.
The rat urine standard extracts (concentrated, dialyzed Wistar or S-D rat urine,
respectively) were antigenically similar. Both gave parallel curves in the assays, and
both assays had a slightly stronger binding to its ÒownÓ standard extract. Using the
other extract would result in a 2.8 or 1.3-fold shift in nominal allergen levels in the
RAST inhibition and in the ELISA assay, respectively.
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Table 7. Comparison between nominal values obtained by the RUA and MUA methods of
the three institutes.
Compared methods No. air
samples#
Ratio, geom mean
(95% confidence interval)
Correlation
coefficient, r2
RUA
NHLI/WAU 40 3 000 (1 900 - 4 900) 0.31
NHLI/NIWL 56 1 700 (1 200 - 2 500) 0.35
WAU/NIWL 38 2.2 (1.6 - 3.1) 0.45
MUA
NHLI/WAU 21 4.6 (2.3 - 9.1) 0.68
NHLI/NIWL 34 5.9 (3.5 - 9.8) 0.64
WAU/NIWL 32 1.6 (1.0 - 2.5) 0.80
# samples with measurable levels by the methods of both institutes were compared.
Comparison between airborne RUA or MUA levels in filter eluates (VI)
The RUA concentrations in filter eluates found by the RAST inhibition (NHLI) was
several orders of magnitude higher than those of the polyclonal (WAU) and monoclonal
(NIWL) sandwich ELISA methods. The MUA levels of the polyclonal competitive
inhibition RIA (NHLI) and sandwich ELISAs (WAU and NIWL) were more similar, as
shown in table 7. The MUA method of the NHLI gave relatively higher values at low
MUA levels and vice versa at high MUA levels when compared with the other two
MUA methods. This suggests that the relationship between the MUA method of the
NHLI and the MUA methods of the other two institutes is concentration dependent.
To test assay performance, 38 rat room filters and 22 mouse rooms filters were
analyzed with respect to both RUA and MUA together with 18 blank filters (table 8).
The NHLI and the NIWL RUA and MUA methods were more sensitive than the WAU
method; however the NHLI method also detected allergen in several of the blank filters.
In order to study the influence of the WAU and NIWL elution methods and of the
immunoassays seperately, the aliquots of eluates from the parallell filters were
exchanged and analyzed. In order to account for reproducibility after storage (about 9
months), the ÒownÓ extracts were re-analyzed simultaneously. Re-analysis showed that
the WAU RUA and MUA levels were 63 and 38%, respectively, of their previous
levels. The NIWL RUA and MUA values were 77 and 109% of the previous values.
Comparison of elution methods (parallel filters extracted with WAU method
compared to NIWL method) showed that using the NIWL elution (gentle rotation with
0.5% Tween 20) gave 10 and 5 times higher RUA and MUA levels, respectively, than
WAU elution (vortexing, sonication, no Tween 20).
Comparison of immunoassays (by measuring the same eluate with both WAU and
NIWL methods) showed that the polyclonal WAU RUA assay gave 4-fold higher levels
than the monoclonal NIWL RUA assay. The two polyclonal MUA methods were again
more similar, the ratio between WAU to NIWL immunoassay values was 0.9.
Study of potential factors influencing antigen detection in the RUA and
MUA immunoassays (VII)
Initial comparisons of protein quantification methods showed that although values for
dust extracts differed between Bradford (NHLI) and bicinchoninic (BCA) methods
(WAU and NIWL), the rat and mouse urinary standard extract values were similar.
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Table 8. RUA and MUA levels in filters from rat rooms and mouse rooms and blank
filters, according to the methods of the three institutes. Modified from VI, submitted.
Rat rooms Mouse  rooms Blank filters
Method N (n.d.#) median
ng/m3
pos.
test %
N (n.d.) median
ng/m3
pos.
test %
N (n.d.) range
ng/m3
pos.
test %
RUA
 NHLI 38 (1) 6 960 97 21 (2) 330 90 18 (10) <10.9 - 1290 44
 WAU 38 (9) 0.62 76 22(20) <0.16 9 17 (16) <0.16 - 0.42 6
 NIWL 38 (1) 2.1 97 22(17) <0.11 23 18 (15) <0.11 - 0.72 17
MUA
 NHLI 29 (11) 2.9 62 13 (1) 17.0 92 10 (7) <4.3 - 5.6 30
 WAU 38 (27) <0.16 29 21(7) 3.0 67 16 (15) <0.16 - 0.43 6
 NIWL 38 (12) 0.29 68 22 (3) 17.3 86 18 (17) <0.11 - 0.18 6
# not detectable
The comparison between sample values obtained using an inhibition assay set-up and
a sandwich ELISA set-up showed, that despite using identical reagents, inhibition gave
values 7-fold higher than ELISA. Just as was observed in the MUA inhibition RIA vs
sandwich ELISA sample values, the ratio between inhibition/sandwich decreased as the
allergen level increased.
Immunoblotting of the RUA and MUA standards and the rat and mouse room dust
samples, detected by the antibodies of the methods, showed that both the standard
antigens and the antibody specificities differed slightly. Unfortunately, MAb
specificities could not be demonstrated by the used methods. Pooled patient anti-RUA
IgE bound to a 21 kd protein in the urine standards, which was not detected by the anti-
RUA polyclonal rabbit Ab. Also, whereas the patient IgE bound diffusely to the rat
room dust, the rabbit Ab gave distinct bands. Although the mouse urinary standards,
which were also used to immunize rabbits, originated from different mouse strains of
different ages, all Ab bound strongly with similar pattern to the 15-18 kd MUA
antigens, and the WAU and NIWL Ab (which gave stronger binding) detected antigens
at 44-50 kd.
The comparisons of RUA assay binding to reference standards and dust extracts
showed that, generally, the different standards were detected similarly, as shown in
figure 9. However, the Rat n 1 (NIWL standard) was not an efficient inhibitor in the
NHLI RAST inhibition assay. Whereas rat room dust was detected similarly to urine in
the RAST inhibition assay, it was detected with 690 and 760-fold less sensitivity than
the urine standards in the polyclonal WAU and the monoclonal NIWL sandwich ELISA
assays, respectively. The MUA assays also detected the urinary standards similarly,
and in contrast to the RUA assays, mouse room dust was detected in all three assays
with 30-52-fold less sensitivity than the urinary standards, see figure 10. All RUA and
MUA assays were specific, and cross-reactivity to other extracts was weak enough so
as to be of little, if any, practical importance.
Antigen aging tests showed that binding of artificially decayed urinary antigen was
only slighly less (90-99% of the inhibition or optical density values) than that of ÒfreshÓ
urinary antigen in the RUA or MUA assays.
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Figure 9. Antigen detection of different extracts in the 3 RUA assays. Submitted.
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Discussion
Prospective study
A great number of cross-sectional studies on laboratory animal allergy have been
published, presenting prevalence data. Only few prospective or follow-up studies have
been undertaken (16, 17, 27, 54, 98, 100). In these studies, subjects with previous
occupational or home exposure to these animals have been included in the analysis -
Davies et al (27) mention that 54% of their subjects had such prior contact with animals.
Thus these studies have followed a number of subjects over a specified amount of time,
irrespective of previous duration of exposure, and recorded new cases of LAA.
One study involved 238 workers unexposed occupationally prior to current
employment (25), but does not present information on pet ownership. The median
exposure duration was 21 months, (range 1 month-less than 4 years), and 21% had
developed work related symptoms, after a median time of 1 year, similar to our study.
Pre-employment atopy and sensitization to laboratory animals were presented in one
study, in which work or home exposure prior to employment in the company was
disregarded. At 2 years of follow-up, the increased relative risk for atopics to develop
sensitization or symptoms to animals was 7.5, and the relative risk was 7.6 to develop
symptoms for subjects previously sensitized to animals (17).
In conclusion, to our knowledge no prospective study has been published, in which
subjects have been investigated, presenting changes from pre-exposure to follow-up
after the first few years of exposure. In order to obtain never-exposed subjects for the
prospective study of laboratory technicians, the pre-investigation was carried out at an
early stage of their education, since many students are exposed to laboratory animals
during their trainee periods. Students from five out of six training schools in Sweden
were invited, and 225 students participated in the pre-employment investigation. Of
these, 168 completed their education and worked as technicians, 43 with laboratory
animals. While most of the 38 who ultimately participated in the follow-up study had
had dogs or cats, and a few had rabbits as pets as children, none had owned a pet rat or
mouse, with the exception of one woman, who had a mouse for one year more than 20
years previously.
The design allowed a study of selection into laboratory animal work. Allergic
diagnosis and SPT positivity were known to the subjects (the latter as a result of
participating in our pre-exposure investigation), but they were unaware of their
Phadiatop and total IgE status before starting to work. Interestingly there was a roughly
doubled prevalence of pre-exposure SPT positives and atopics among non-animal
workers (not significant).
A second consequence of the design was that it allowed longitudinal comparison with
a well-matched unexposed group. This has to our knowledge not been reported before.
The point was to investigate to what extent laboratory animal exposure per se, in a
group of subjects with certain characteristics, would provoke allergy, immunology or
lung function changes among the exposed, and among matched unexposed. We did
find a tendency of increased general prevalence of allergic symptoms (to any allergens)
in the exposed group (reported asthma symptoms were significantly increased).
However, also non-exposed subjects showed similar increases in allergic symptoms.
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The cause of this is enigmatic. Possibly the increase in symptoms reported by both
groups at follow-up is partly a result of increased awareness as a result of participating
in the study. However, environmental exposures other than laboratory animals
(occupational or not) may also have contributed to the increase.
Development of sensitization and symptoms
All of the exposed subjects were SPT negative to laboratory animals prior to exposure.
Only 16% were atopic according to Phadiatop, 10% had rhinitis or conjuctivitis and
only one subject had experienced asthma symptoms, on the whole a healthy group of
mostly young female students, rather less allergic or atopic than those of several other
studies (16, 18, 25). Two years after graduation, they were followed up, and found to
have worked with laboratory animals, mostly rodents, for about 1.5 years. In this short
time, 18% had developed STP positivity to rodents, and 21% had experienced
symptoms, mostly mild, during animal work. One individual, however, had developed
symptoms such that she left after 14 months to pursue another career. Although some
subjects were exposed to other animals, we found no indications of sensitization or
symptoms against them. In accordance with Hollander et al (46), rats seemed to be
more allergenic than mice.
Three of the technicians reported chest symptoms related to exposure to laboratory
animals. The symptoms had been identified and treated as asthma in one subject at the
time of investigation, and another subject, with high levels of specific IgE against rat,
subsequently needed asthma medication.
Changes in lung function
The prospective design, with measurements prior to first exposure, allowed a more
detailed description of changes induced by the animal allergens than would have been
possible in a cross-sectional study. In six of nine sensitized and/or symptomatic
subjects, a more than threefold decrease in PD20 was observed. This suggests that a
majority of sensitized subjects with early reactions to laboratory animal allergens,
develop increased bronchial responsiveness after a short time of work exposure. This
has not been demonstrated earlier. Newill et al (72) reported an association between
LAA and bronchial hyperresponsiveness, in a study where subjects who had reported
chest symptoms at animal contact were excluded from the analysis. A significantly
higher percentage of symptomatic subjects were defined as having bronchial
hyperresponsiveness compared to non-symptomatic animal exposed. In the present
study, it was confirmed that bronchial hyperresponsiveness can be demonstrated also in
subjects who do not report chest symptoms. In a cross-sectional study by Hollander et
al (47), peak-flow (PEF) measurements  measurements were performed in subjects on
days working with animals, and on non-animal working days in 209 subjects. No
difference in PEF variability was found between days with and without animal contact,
even among subjects with chest symptoms to rats (n=14), although PEF variability in
these subjects was higher (p<0.05) than in subjects without chest symptoms. However,
significant differences were found, with slightly higher PEF amplitudes (PEF max-PEF
min) in rat sensitized (n=38) compared to non-sensitized subjects (n=169).
In a cross-sectional study by Willers et al (123), methacholine provocation was
performed. The volume of trapped gas (a measure of small airways function) was
found to be significantly increased in 7 workers highly sensitized (³3+) to laboratory
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animals compared to 30 non-sensitized laboratory animal exposed. In a 7-year follow-
up study of subjects exposed 1-31 years at first examination (98), VC and FEV1 were,
as in our study, no different between sensitized/non-sensitized, but bronchial
responsiveness by methacholine provocation was significantly higher among STP
positive subjects at follow-up, (also SPT positive at first examination), while
unchanged among non-sensitized. However, the majority of sensitized (of which 5
asthmatics) had discontinued their exposure during the follow-up time. None of these
studies, however, demonstrate an increase in responsiveness over time associated with
sensitization to laboratory animals.
Altogether, the above results and ours suggest that bronchial responsiveness
increases in most laboratory animal sensitized subjects, even before any lower airway
symptoms appear. Possibly sensitization against laboratory animals, and the
accompanying changes of the airways, may facilitate reactions to other airborne
allergens, and induce non-specific bronchial hyperreactivity.
Exposure and LAA
Those who developed sensitization or symptoms worked significantly more
hours/month with rodents. Nine sensitized/symptomatic (ÒLAAÓ subjects), were
matched for atopy with exposed non-LAA subjects. Eight of the 9 LAA subjects had
worked with mainly or exclusively male rodents, compared to only 1/8 non-LAA
subjects. In the present literature of allergy to laboratory animals, one paper mentions
rodent gender in the context that of 15 allergic to rats, 14 had been working with male
animals (2). However, it was not stated whether that implied exclusive, main, or some
exposure to male animals. We wished to further investigate whether exposure to male
rodents constituted an overlooked risk factor in a larger group of subjects, with longer
exposure time.
The fact that mature male rodents excrete potent urinary allergens in up to hundreds
of times higher amounts than female rodents (39, 63, 64, 70, 73, 91, 94, 116) hinted
strongly that male rodents could be more allergenic, but the role of animal gender as a
risk factor has not been studied previously.
The working environment for laboratory animal exposed personnel had progressively
been improved over the last decade in the university facility visited in the cross-sectional
study, as in other facilities, with main ventilation improvements, animal facility
refurbishments, the gradual installation of ventilated benches and cabinets, as well as
with improvements in work routines and use of personal protective devices. The work
allergen load is thus likely to have decreased over the years. As most air samples from
research laboratories were below detection level (<0.26 ng/m
3
 for RUA, <0.8 ng/m
3
for MUA, respectively), research staff working with special ventilation solutions, such
as ventilated benches or cabinets, should be exposed to minimal allergen amounts.
Furthermore, our aeroallergen methods were found to be at least as sensitive as those of
other laboratories, especially when using amplification (papers IV and VI). Correcting
for methodological differences, other laboratories have found higher allergen levels in
both animal confinement buildings and research laboratories (49, 75), which seems to
indicate that the levels found in the study were indeed low.
We studied whether it was possible to avoid sensitization among staff who had
worked less than 4 years in research laboratories, using ventilated benches or similar
solutions (n=26). The division at 4 years of exposure was chosen to conform with
other studies (25, 48). We found that 3 (12%) were sensitized (all of whom were atopic
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or had an elevated total IgE, and had worked with male rodents) and 6 (23%) reported
symptoms .
Among all those exposed £4 years (n=48), 23% were either sensitized or
symptomatic against the rodents, and 8% were both. Among those exposed >4 years
(n=31) 48% were either/or and 39% were both sensitized and symptomatic. Possibly a
number of the shorter exposed either sensitized or symptomatic, will eventually develop
both, in accordance with one study (17), in which a positive SPT predicted a
subsequent development of LAA with more than 80% accuracy.
There are several possible explanations for the higher prevalence of sensitization and
symptoms against rodents noted among the longer exposed subjects. The low exposure
may have lead to a delayed onset of sensitization, instead of the 1-3 years usually found
(51). Additionally, although these subjects did not work more hours/week with
rodents, they worked to a greater degree with male rodents. Also, this group may have
had a higher exposure in the past. Interestingly, most of the long exposed LAA subjects
had been skin prick test or RAST positive to rodents previously. Instead of healthy
worker selection, which has been offered as the possible cause for fewer LAA subjects
in high exposure groups (62, 117), these research department workers remained at
work, despite having experienced symptoms and being aware of their sensitization
(Óstubborn workersÓ). Thus the exposure levels were perhaps low enough to continue
working, with managable symptoms, yet high enough maintain sensitization. It is of
course possible that additional staff have left because of LAA. However, in the follow-
up study of Kibby et al (54), allergic subjects (especially college educated) were as
likely as non-allergics to participate in the follow-up.
We did find indications that working with male rodents was an independant risk
factor for LAA sensitization and symptoms. Subjects with both atopy and male rodent
work had an 11-fold higher rodent sensitization prevalence compared to those with
neither risk factor. Among these low exposed subjects, working with mainly male
rodents appeared to be better correlated to LAA than working many hours/week with
rodents. However, both factors were correlated (P<0.01). Similarly to a previous study
(54), use of gloves and/or ventilated benches in this environment did not appear to
protect from sensitization or symptoms. Conclusions are however uncertain, since LAA
subjects might be more inclined to use such protection.
We found that sensitization to one of the rodents was significantly associated with
sensitization to the other (P<0.0001). The reasons for this immunological cross-
reactivity might be that the rodent allergens, both Mus m 1 and Rat n 1 and rodent
albumins, are closely related (21, 120). Skin prick test cross-reactivity between rat and
mouse allergens and between guinea pig and hamster allergens has been noted in
another study (2).The observation that subjects allergic to other fur animals were at
higher risk to be sensitized or symptomatic, is entirely in accordance with the results of
another cross-sectional study (46).
In conclusion, exposure to male rodents seems to be an overlooked risk factor. We
suggest that to further diminish allergen load, and LAA development, female rodents
should be used when possible. Botham et al showed, in an improved working
environment, that first year LAA symptom incidence decreased (but was not entirely
abolished), yet LAA sensitization was high (16, 17). It is possible, that among our
cross-sectional subjects with £4 years work in these low exposure surroundings, fewer
will develop both sensitization and symptoms against the animals. However, the
allergen level threshold for sensitization and maintenance of specific IgE appears low
indeed.
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Prediction of LAA
Elevated pre-exposure total-IgE levels gave the best predictive values for
development of LAA in our prospective study. This was also indicated in both LAA
asthma and test positive rhinitis groups compared to non-symptomatics in another of the
few studies that have measured total IgE (100). Predictive values were generally low
for the other parameters studied from before exposure. In earlier reports comparing
several criteria of atopy (99, 103) results were similar. The presence of atopy (by any
definition) or of elevated total IgE, correctly predict LAA to no more than, at best, 50%.
Risk indicators must be highly sensitive and specific to result in useful prediction, even
in a common occupational disease such as LAA. Thus if atopy or total IgE were to be
used as a screening instrument prior to employment, many competent individuals would
be refused employment, entirely unneccessarily. Therefore, judging from our results
and others, both atopy and total IgE are too blunt instruments for personnel selection
into general laboratory animal work.
We found high risks to develop LAA when host factors and exposure factors were
combined. Hollander et al (48) showed that exposure intensity is of importance for
LAA, with atopy as a strong effect modifier, resulting in steeper exposure-response
curves. For example, an atopic individual may manage fine in a laboratory setting, with
a few hours of work per week on female rodents, but may increase the risk to develop
allergy considerably, if instead working many hours per week with male rats, or if
working in animal rooms. The risk to develop LAA would probably increase further, if
he/she was already allergic to other fur animals. An attempt to rank several risk factors
and estimate predictive values for them (based on many studies, both cross-sectional
and follow-up) is found in table 9.
Table 9. Estimated predictive values of some potential risk factors.
Risk factor Predictive value (of +++++)
Smoking (+)
Lung function, VC or FEV1 (LAA asthma +)
Bronchial hyperresponsiveness + (LAA asthma ++)
Family history of allergy +(+) (allergic mother ++)
Personal history of allergy ++
Personal history of asthma +++
Personal history of allergy to pets +++
SPT positivity or spec. IgE to common
aeroallergens
++
SPT positivity or spec. IgE to pets +++
SPT positivity or spec. IgE to laboratory animals ++++
Phadiatop positivity ++
Total IgE ³ 100 kU/l ++(+)
High allergen exposure (many hours/week and/or
work with male rodents)
++
Total IgE ³ 100 kU/l and high exposure to
allergen
+++(+)
Allergy to pets and high exposure to allergen +++(+)
Total IgE ³ 100 kU/l and asthma to pets and high
exposure to allergen
++++(+)
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In conclusion, 1) positive IgE tests to laboratory animals predicts LAA with high
accuracy; 2) different markers for atopy (Phadiatop positivity, positive SPT to common
aeroallergens) or high total IgE are not sufficiently good predictors to be use dfor
selection. However sensitization or allergy to other fur animals appears to be well
correlated with LAA. Atopy and elevated total IgE appears to be a good predictor of
senstitisation to laboratory animals in environments with high exposure to male rodents.
Development of methods to measure airborne allergens
Although exposure proxies, such as job title, or hours/week of animal work, provide
valuable information, exposure measurements are also important in the investigation of
laboratory animal allergy. Quantification of aeroallergens is also necessary to enable
exposure surveillance or for the evaluation of ventilation improvements.
One of the aims was possibility of standardization. Therefore efforts were made to
develop monoclonal antibodies against the major rodent allergens. MAbs against the
highly allergenic Rat n 1 isoallergens were successfully produced, making it possible to
establish an assay against primarily Rat n 1.02 (a2u-globulin). The MAb sandwich
ELISA thus captures a marker for allergen load, similarly to using monoclonals against
Fel d 1 or Can f 1 to determine airborne cat and dog allergen levels (55). Utilising
monoclonal antibodies in the detection of airborne rat allergens has to our knowledge
not been described previously. Unfortunately, efforts to produce MAbs against Mus m
1 were not successful. However, as it transpired from the European comparison
between methods to measure mouse urinary allergens, Mus m 1 has a dominant role in
both urine, dust, and as an antigen. Therefore, polyclonal methods, even if based on
different mouse strains, performed with different set-ups and methods of detection,
gave similar values.
Some studies indicated that low exposure to allergens might be of clinical importance:
Eggleston had showed that low Rat n 1 levels may provoke immediate reactions in
sensitized subjects (30), and in another study, repeated inhalation of very low
(subclinical) doses of allergen gave increased airway responsiveness in allergics (52).
Therefore, another goal was to devise sensitive methods. An in-house method of signal
amplification was developed using a newly synthesised amplifier, which further
increased sensitivity tenfold. This amplifier is also used in this laboratory for the
measurement of cat aeroallergens in schools, sampled with personal pumps at 2 l/min
(60). The amplification method was found to give values which corresponded very well
with those obtained when using a commercial amplification kit. However, despite using
amplification to assess RUA in the cross-sectional study, most samples from
laboratories were below detection limit.
Comparisons between different aeroallergen measurement methods
The first comparison between measurement methods was initiated since RUA levels in
animal confinement buildings reported by another laboratory, using RAST inhibition,
differed greatly from the values found in our laboratory. The study, in which 40
samples were collected, aliquoted and analyzed by both methods, gave a 300-fold
difference between values in one and the same extract, although the correlation was
good (except in samples with high albumin content). Furthermore, in the RAST
inhibition assay, the samples collected and eluted in Sweden contained higher RUA
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levels than the UK samples, whereas according to the MAb ELISA method, the levels
of Rat n 1.02 (a2u-globulin) were similar.
The variations between methods in sampling and elution (buffers, types of filter,
freeze-drying etc) might account for some of the difference in the levels observed
between UK and Swedish samples. However, the factor thought to be of most
importance for the RUA elution, the concentration of Tween 20 (38) in the elution
buffer, was identical in both protocols.
The main explanation of the great difference in values must thus lie in the specificities
of the antibodies, and the fundamental differences in assay design.
One method used patient serum and the other monoclonal antibodies detecting Rat n
1.02; other allergenic proteins deriving from for instance fur or saliva may be present.
However, Rat n 1.02 is a dominant urinary protein and was shown to be present and
stable in both airborne and accumulated animal house dust (40), so this difference was
estimated to influence the resulting values to a minor extent.
The methods might detect dust and urine differently, since dust was a fivefold more
potent inhibitor than rat urine in the RAST inhibition assay, in a prior observation made
by Gordon et al (40), and this would result in relatively higher nominal RUA values. In
the sandwich ELISA assay, for detection of rat urinary antigen, the protein must contain
two conserved epitopes orientated spatially so that each MAb may bind. Little is known
about the stability of these epitopes in the occupational environment, or during the
collection, elution and assay procedures. Degradation of the proteins might potentially
result in a relative increase of RUA in an inhibition style assay, and a relative decrease
in a 2-site binding assay. These queries were further investigated in the 3-country
study.
In the RAST inhibition, the presence of large amounts of IgG, some of which is
specific for RUA (15, 82), might influence the values by competing with the specific
IgE for available allergen. It can be estimated that in the standard curve wells, each IgE
antibody is surrounded by from a few to half a million urinary antigen molecules, and
thousands of IgG molecules. In another RAST inhibition assay described by Eggleston
(31), IgG was removed by precipitation with goat-antihuman IgG, and Rat n 1 was
used as the standard extract. By this method, levels were more similar to those found in
our laboratory.
To summarise, we demonstrated that it was difficult to compare air sampling values
from different laboratories, and that several factors might influence the nominal values.
In the European Concerted Action project, the need for further study was recognized
and both RUA and MUA methods were compared. These studies provided additional
insight about the factors influencing antigen detection and resulting sample values, and
a tentative recommendation for future aeroallergen sampling and analysis could be
suggested.
Filters were collected in all three countries in triplicate, each country received one set
of filters (including blank filters), which were eluted and aliquoted, so that also aliquots
could be exchanged and analyzed by another countryÕs method. The analysis of parallel
filters verified the observation that the RAST inhibition method generated values several
orders of magnitude higher than those obtained by sandwich ELISA: RUA values were
3000-fold and 1700-fold higher than those in the polyclonal and monoclonal ELISA,
respectively. MUA levels, measured using polyclonal rabbit antibodies, were less
different; inhibition RIA gave values 5-6-fold higher than sandwich ELISA. The NIWL
RUA and MUA sandwich ELISAs gave values about two-fold higher than the WAU
methods. The methods of the WAU and NIWL gave only a few false positive values,
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i.e. RUA and MUA were detected in only a few blank filters, whereas the RUA method
of the NHLI detected RUA in 44% of the blank filters. The reason for this might be the
high variability of the inhibition assays. Furthermore, the detection limit of the WAU
assay was determined by analysing extracts of 126 blank filters, and setting a cutoff
value at the mean value obtained for the blanks +2 SD. The NIWL methods used the
lowest standard point as detection limit, but the methods were highly reproducible also
in the low concentration range. However, it is possible that not only the immunoassays,
but also handling of filters and extracts or contamination between tubes or wells may
give a positive blank.
The set-up of the sampling allowed for conclusions to be drawn about the importance
of elution methods, and storage stability. The elution method of the NIWL gave
approximately 10 and 5 times higher RUA and MUA levels than the elution method of
the WAU, respectively. The major differences between the methods were agitation
technique and the addition of 0.5% Tween, previously shown to increase RUA yield
(38). One study on proteins derived from potatoes (125), found that sonication plus
vortexing gave a 13% higher yield than gentle shaking. In our study the differences in
elution between the WAU and NIWL methods are therefore probably due to the
addition of Tween in the elution buffer of the NIWL.
The polyclonal RUA immunoassay of the WAU gave approximately 4 times higher
values than the monoclonal NIWL method. These differences could not be explained by
type of immunoassay used, because both institutes used a sandwich immunoassay. In
contrast to the RUA immunoassays, the polyclonal MUA immunoassays showed no
significant difference in allergens levels between the WAU and NIWL assay. The
differences between the RUA levels derived from the WAU and NIWL immunoassays
are therefore probably due to the type of antibodies used.
Furthermore, the methods of the WAU showed a large decrease in allergens level
after a storage period of the extract of 9 months at - 20°C. This decrease was not present
in the extracts of the NIWL, which was probably due to the addition of BSA and
Tween to the elution buffer (119).
In the further investigation of factors influencing antigen detection in the assays, the
protein quantification methods of the laboratories were compared, the Bio-Rad
Bradford and the Pierce BCA method. The latter gave higher values, especially for
undialyzed dust extracts, which contained partially degraded proteins, peptides or uric
acid etc, that may also be detected or interfere in the BCA assay (105) (56). Moreover,
in Bradford assays, the standard used, BSA, gives about twofold higher values than
many other proteins (80). For experiment consistency, protein was quantified using the
Pierce BCA kit, by one individual in one laboratory.
When using identical antibodies and standard extracts in a sandwich EIA and an
inhibition EIA, respectively, the set-up of the assay contributed to a 7-fold difference
between nominal RUA values. One reason for this phenomenon could be that antigen
epitopes may be presented differently in solution compared to if bound. Binding to a
plate or disk changes the three-dimensional structure of the molecules (14).
The Western blots showed that the specificities of the anti-RUA antibodies differed,
whereas the MUA antibodies bound with similar pattern to the antigens. We speculate
that the ability of the Mus m 1 affinity purified antibodies (NIWL) to bind to the 44-50
kd allergens, suggests that these might be dimer forms of Mus m 1.
In agreement with the previous comparison, all concentrated, dialyzed urine standard
extracts were detected similarly in the MUA and RUA assays. However, the Rat n 1
standard used in the MAb assay was inefficient as an inhibitor in the RAST assay
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compared to the other urine standards, indicating that a significant amount of the patient
pool Ab were specific for other rat urinary proteins, which was confirmed in the
Western blots.
However, the major difference between RUA RAST inhibition and sandwich EIA
assays, was in the detection of rat room dust. Whereas the sandwich methods were
700-800-fold less sensitive to this extract, it was detected with the same potency as rat
urine by the patient serum pool. If the dust extract closely approximates air sample
eluates, this could explain a major part of RAST inhibition sample values being higher
than EIA values. The dust extract (containing dust from bedding, food, faeces, hair,
etc) was as potent an inhibitor in the RAST assay as rat urinary allergen by protein
content (as measured with Pierce BCA method). Food and mouse room dust extracts
did not react in the RAST inhibition, suggesting that the antigens are rat-derived,
perhaps rat dander or hair play a part. A further explanation is that urinary antigens
from dust might be presented in a form more readily recognized by the patient pool IgE,
since the patientsÕ immune system developed Ab to inhaled dust, rather than dialyzed
urine. Conversely, the rabbit or mouse Ab were from animals actively immunized with
mouse and rat urinary proteins. Although the EIA methods may measure the present rat
urinary allergens in air samples, they may underestimate the clinical allergenic potency
of an air sample.
In the rabbit polyclonal MUA assays, detection of urine standards was similar. In
contrast to the RUA assays, all bound to mouse room dust with 30-50-fold less
sensitivity than to mouse urine. All RUA and MUA assays were specific; binding to
other allergen extracts was weak enough so as to be of very limited, if any, practical
importance for the measurement of RUA or MUA in air samples.
Swanson et al (112), measuring airborne mite allergens in samples using
monoclonals, rabbit polyclonals or human sera as detection antibodies, found that
human sera gave about twentyfold higher values than the others. The antibody source
thus affects the dynamics of an immunoassay. A MAb has a specific affinity to one
epitope, whereas rabbit polyclonal or patient serum antibodies display a spectrum of
affinities and epitope specificities. The antigen-antibody curve in a polyclonal assay is
thus the sum of several simultaneous dynamic equilibriums.
The inhibition standard curves are considerably less steep than the sandwich EIA
curves. As a result, a small difference in inhibition will give a large difference in
nominal allergen level, and a larger measurement variability.
In the ÒagingÓ experiment, all RUA or MUA assays detected decayed antigen
marginally less than fresh antigen. Aging is thus unlikely to greatly affect the nominal
values. It is, however, possible that the accelerated degradation protocol used is not
representative of natural antigen breakdown.
In conclusion, large differences can be found between the various methods to
measure aeroallergens. For estimation of total allergen exposure, for clinical purposes,
polyclonal assays may be useful. However, to enable comparison between
epidemiological or allergen control studies, and certainly before any meaningful
occupational exposure limits can be proposed, standardization is necessary. We found
several factors contributing to differences in nominal levels of allergen measured in air
samples. The type and source of the antibodies accounted for the greatest discrepancy
between the RUA methods, because of their different specificities and affinities. Assay
set-up also contributed, with inhibition giving about 7-fold higher values. The use of
Tween and BSA enhanced extraction efficiency up to about tenfold and improved
stability during storage.
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However, what is measured by any immunological method is a marker of allergen
load: the amount of a certain molecule or molecules detected by a set of antibodies in an
extract of what has been eluted from a filter. It is not the actual dose of airborne allergen
inhaled and potentially reacting with the immune system of an individual.
Suggestions for standardization of assays
The comparison of assays performed in these studies were the first steps towards
standardization. In general, the differences between the methods were systematic and
conversion factors may be used to compare or exchange data of already performed
exposure measurements. However, there are several limitations of the use of
conversion factors. For instance, inhibition gave a deviation from a linear relationship
when compared with sandwich ELISA, giving a higher inhibition to sandwich value
ratio at lower concentrations and vice versa, the reasons for which are yet unclear.
Additional limitations are differences in sampling strategy, and definitions of job titles
and tasks. For future sampling, standardization is preferred.
The ideal assay would combine simplicity, sensitivity and reproducibility over time
with a good correspondance to clinical symptoms provoked by the environment.
Standardization has in the last decade or so been achieved by the use of monoclonal
antibody based assays, such as the commercially available airborne allergen ELISA
assays for cat allergen Fel d 1 (20). Unlike the cat where there is thought to be one
major allergen, Fel d 1 (65), the rat is more complex and three major allergens have
been identified (40). Rat n 1.02 is however an ideal candidate for a rat allergen marker
protein as 1) it is a major allergen for nearly all rat allergic subjects (39, 49) 2) it is
present in both airborne and accumulated animal house dust (40) and 3) there is
knowledge of some of the factors which may influence its excretion, such as the age
and sex of the rats (39). In the case of RUA, the described MAb assay is specific to this
allergen and it is possible to standardize both antibodies and standard extract. The
disadvantage is that it does not detect several allergens present in rat urine or dust, thus
potentially underestimating the clinical allergenic load. To our knowledge, no-one has
produced MAbs against mouse urinary antigen. However, mouse urine has one
dominant allergen, the Mus m 1 complex, and the three different polyclonal assays were
found to give values within the same order of magnitude. Further standardization can be
achieved by the aquisition of large amounts of both antibodies, standard extracts and
controls, which should be well characterised, and using them in a sandwich ELISA.
Furthermore, when necessary, sensitivity may be enhanced using commercially
available or in-house signal amplification methods.
To conclude, to enable comparisons between studies, for allergen control or to
establish thresholds for sensitization/symptoms, we recommend sandwich ELISAs
against major allergens, preferrably using monoclonal antibodies. Standardization of
polyclonal sandwich assays is possible using purified polyclonal antibodies and
specified allergen extracts. Since the addition of Tween and BSA significantly increased
elution and eluate stability we recommend its use in future aeroallergen filter sampling.
Prevention and legislation
According to the Swedish Work Environment Act (1977:1160, reprinted 1991:677), the
employer bears the main responsibility for providing a safe workplace. Thus: Òworking
conditions shall be adapted to peopleÕs differing physical and mental aptitudesÓ (chapter
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2, section 1) and Òwork shall be planned and arranged in such a way that it can be
carried out in healthy and safe surroundingsÓ (chapter 2, section 2). Furthermore, Òthe
employer shall ensure that the employee acquires a sound knowledge of the conditions
in which work is conducted and that he is informed of the hazards which the work may
entail. The employer shall make sure that the employee has received the training
necessary and that he knows what measures must be taken for the avoidance of risks in
the workÓ (chapter 3, section 3). This is also prescribed by the National Board of
Occupational Safety and Health (Arbetarskyddsstyrelsen) (7). Up to 1995, 4000
Swedish laboratory animal exposed personnel had undergone such education, in which
information on laboratory animal allergy should be a natural part.
However, also the employee has responsibilities: according to the Act, the employee
is under obligation to Òtake part in the implementation of the measures needed in order
to achieve a good working environment. He shall comply with directions issued and
use the safety devices and exercise such other precautions as are needed for the
prevention of ill health or accidentsÓ (chapter 3, section 4).
In AFS 1990:11, ¤12 states: ÒThe employer shall offer employees, who routinely
will work with allergy causing laboratory animals, medical examination prior to
commencement of work. Also, the Swedish Work Environment Act, chapter 4, section
5, states ÒA prohibition may also be issued against the use in such work of any person
whom medical examination has shown to be suffering from a disease of weakness
rendering him particularly vulnerable to such a riskÓ. As indicated by the predictive
values, host factors such as various indicators of atopy, are of little value as selection
instruments. Selection of staff based upon prior atopy or allergy will not prevent the
occurence of LAA, but would exclude a large proportion of subjects who will not
develop LAA, from the workforce. The medical examination should instead be used to
inform the worker of his/her particular risks, and encourage suitable preventive
measures. However, individuals with pre-exposure sensitization to laboratory rodents,
combined with a history of personal allergy or asthma against fur animals, should be
discouraged from employment with high exposure to rodents, since they will be highly
susceptible to developing LAA, which might also further exacerbate the prior
allergy/asthma. A medical investigation should include tests such as skin prick tests or
Phadiatop, total IgE and specific IgE to the laboratory animals in question. Also, if
possible, bronchial provocation should be carried out.
The primary instrument for prevention of LAA should not be selection of personnel,
but protection by minimizing exposure. In general, employers now seek to reduce
environmental allergen exposure by installing efficient ventilation systems and
ventilated laboratory benches, use of better cage cleaning practices and bedding material
(36, 88, 109). One example is the sliding curtain system (described in paper IV), which
improved the environment in the aisle of the animal rooms. Several other solutions are
being evaluated, such as vacuum removal of litter, or ventilated cage systems (41, 90).
We also showed that working with male rodents appears to constitute a higher risk than
females (paper III), and recommend increased use of females, whenever possible.
Although we could not determine any preventive effects of glove use (possibly
because allergics might be more inclined to use gloves), it is logical to assume that a
consistent use of gloves (and long-sleeved laboratory coats) at least should prevent the
appearance of LAA skin symptoms. Furthermore, sensitization via skin might facilitate
the appearance of subsequent airway symptoms. In high-allergen load situations, and
for subjects at high risk to develop LAA, use of filtered-air helmets is recommended
(89, 104). Also cleaning and maintenance personnel must be informed of risks and
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proper work routines. A study by Botham et al (16), showed that education, a medical
examination, and improved work routines, indeed did reduce the percentage of subjects
developing symptoms against laboratory animals in the first year of employment, from
previously close to 40%, to about 10%.
Management of LAA
According to AFS 1990:11, ÒIf an employee working with laboratory animals develops
symptoms indicative of allergy or other hypersensitivity, the employer shall furthermore
offer medical examination....The employee shall receive the information and the advice
motivated by the result of the medical investigationÓ.
If an individual has developed LAA, to prevent early, mild symptoms from
developing into more severe symptoms or LAA asthma, several courses of action
should be taken. The first priority would be to diminish allergen exposure, by
increasing the use of personal protection and decreasing the amount of time in contact
with animals as much as possible. If necessary, medical therapy may include
antihistamines, steroids, decongestants or bronchodilators.
Also, the employer should be informed, and an inspection of the workplace might
reveal flaws in animal handling routines which might be rectified. In Sweden,
employees are required to report occupational injuries and diseases to the employer, and
national statistics are collected at the National Board of Occupational Safety and Health,
at the Occupational Injury Statistics Division. Between 1990-1996, 22 subjects
involved with research reported LAA, and between 1992-1996 only one case of
suspected anaphylaxis due to a mouse bite was reported (Brje Bengtsson, personal
communication). Since investigations on LAA performed in Sweden have showed a
prevalence of between 20-50% of sensitization or symptoms [(2, 10), Krister Iwarsson
and Per-ke hrsten, personal communication], this disease is seriously
underreported.
Some LAA subjects cannot continue working with animals. In a follow-up study by
Sjstedt et al (98), 9/11 SPT positive subjects had stopped working with animals
(including all who had developed asthma) compared to 7/24 SPT negative subjects.
A summary of recommendations for the prevention and management of LAA is
provided on next page.
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Recommendations
for management of allergy against laboratory animals
Preventive measures for new personnel
1. Information: regulations, risk factors, symptoms, treatment
2. Demonstration of general and personal protective equipment
3. Information on local laboratory and animal handling routines
4. Medical examination, which should include questionnaire, Phadiatop or skin prick 
tests, specific IgE to fur animals including the laboratory animals in question, 
total IgE, bronchial provocation if possible. This should be annually repeated.
Management of LAA
For the individual with LAA:
1. Decrease of exposure through 
- increased use of personal and general protective equipment
- decreased exposure time
2. Medical examination, medication if necessary. Follow-up to assess 
improvement
3. Report to nearest superior, safety officer and to employer
(4. If necessary: relocation.)
For the employer:
1. Report occupational disease/injury to (in Sweden) the Occupational Injury 
Statistics Division at the National Board of Occupational Safety and 
Health
2. Investigate work routines, ensure availability of safety equipment
3. Long-term investment in improved working environment, e g of general 
ventilation, installation of automated cage washing and ventilated benches. 
Transport of animals should be performed with minimal allergen spread.
 We recommend 3 seperated work zones:
Research laboratories and offices (no animal work)
Animal research laboratories (restricted access, clothes change)
Animal confinement area (animal caretakers only, clothes change)
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Conclusions
· An elevated total IgE predicts the early development of sensitization or symptoms
against laboratory rodents.
 
· Most subjects who are sensitized against laboratory rodents develop increased
bronchial responsiveness.
 
· Subjects with intense exposure to male rodents (who excrete much higher levels of
urinary allergen) are at increased risk to develop LAA
 
· Subjects with a combination of atopy or elevated total IgE, and relatively high
exposure to rodents, highly risk to be symptomatic and/or sensitized against
laboratory animals, even in ÒcleanÓ laboratory environments.
 
· Immunological methods to measure rodent aeroallergen exposure may give nominal
allergen levels that differ widely, yet are correlated, allowing conclusions to be
generalised.
· The reasons for differences in measured levels are mainly due to assay set-up
(inhibition/sandwich) and choice of allergen detecting antibodies.
· Use of Tween and BSA in the elution buffer improves elution and extract stability. If
needed, assay sensitivity may be enhanced using in-house or commercially available
signal amplifiers.
 
· Standardization of aeroallergen measurement methods may be achieved by the use of
sandwich ELISAs with defined and sensitized antibodies and extracts.
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Suggestions for future research
Longitudinal studies with repeated investigation and extended follow-up time are
required to further explore several risk factors that have been suggested by these and
other studies on LAA. One question is whether allergy or sensitization to other fur
animals precedes LAA development, or is coincidental with LAA.
Atopics might differ from non-atopics with respect to exposure threshold for
developing LAA. Furthermore, the threshold for sensitization or symptom development
might differ, and additional information is needed about which levels of exposure may
maintain already developed sensitization and symptoms.
The protective value of routinely using gloves or other personal protective equipment
from the beginning of exposure have not been ascertained.
The pattern of exposure may perhaps be important, and subjects occasionally report
development of symptoms at returning to exposure after a period of absence. This
observation might indicate an effect on the immune system resembling development of
symptoms to seasonal aeroallergens, and requires further study.
Another point of interest which might be adressed in longitudinal studies, is whether
some individuals - and if so, which individuals - might initially react to animals but
subsequently adapt through down-regulation of the immune response.
A number of studies have shown that, although being constantly exposed to high
levels of allergen, fewer among animal department staff have LAA compared to low
exposed research staff. This is usually attributed to healthy worker selection. However,
it is conceivable, that animal house exposure is different than laboratory exposure, in
that dust levels are higher, and that the dust may contain endotoxin or other agents
which might induce immune responses of the TH1-type (with IFN-g and IL-2
production) rather than TH2 (with production of IL-4 and IgE).
Initial genetic studies have suggested that certain patterns of genetic setup might
decrease or increase susceptibility to LAA development, however, more research is
needed in this area. Also, studies of the allergenic epitopes present on the rodent
allergens, for instance the Rat n 1 or Mus m 1 isoallergens, may provide interesting
information.
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Summary
Anne Renstrm. Allergy to laboratory animals. Risk factors for development of allergy
and methods for measuring airborne rodent allergens. Arbete och Hlsa 1997; 26.
Between 10-50% of workers exposed to laboratory animals, mainly rats or mice,
develop laboratory animal allergy (LAA) with symptoms of rhinitis, conjuctivitis,
asthma, or urticaria, and develop IgE against animal allergens. Symptoms often arise
within the first years of animal work. Up to half of the symptomatic subjects have
asthma. One aim of the thesis was to determine risk factors for LAA, especially in
laboratory environments. A second aim was to develop methods to quantify
aeroallergen exposure.
In a prospective study, 225 laboratory technician students were investigated. Two
years after graduation, those who were laboratory animal exposed (median exposure 18
months) were re-examined (n=38). We found indications that atopics were under-
represented among those who subsequently worked with animals. Seven exposed
(18%) had skin prick test positivity (sensitization) to laboratory rodents and 8 (21%)
had experienced allergic symptoms at animal work. Those sensitized and/or
symptomatic (n=9) against laboratory animals had an increased bronchial
responsiveness compared to at pre-exposure (P<0.01), and compared to exposed
without sensitization or symptoms (P<0.05). Elevated total IgE (P<0.01) and
hours/month of exposure (P<0.05), were both risk factors for LAA.
The risk of developing LAA in research departments with low exposure was
investigated in a cross-sectional study (n=80). A fourth of those with £4 years of
rodent exposure were sensitized or symptomatic whereas half of those with >4 years of
exposure were sensitized or symptomatic. Risk factors for LAA were Phadiatop
positivity, elevated total IgE, allergy to other fur animals and exposure to mainly male
rodents. For subjects with both exposure to male rodents and elevated total IgE or
positive Phadiatop, the prevalence of sensitization was 11-fold higher compared to
subjects with neither risk factor. Thus, exposure to male rodents, who excrete up to
hundreds of times higher levels of urinary allergen than females, may constitute an
overlooked riskfactor. Even low exposure to allergen seems to maintain allergic
symptoms and specific IgE.
To measure airborne rat urinary allergens (RUA), a two-monoclonal sandwich
ELISA was developed, specific for the potent Rat n 1 isoallergens. An amplification
method was developed, which increased sensitivity tenfold, to 0.1 ng/m3 in one-hour
air samples collected at 2 l/min. A polyclonal sandwich ELISA for mouse urinary
allergen (MUA) measurement was developed against the main allergen complex Mus m
1, with detection limit 1 ng/m3.
The ELISA RUA method was compared with a RAST inhibition method developed
by a laboratory in the UK. Samples were collected in each country, and analyzed in
both laboratories. The values were correlated (r2 of log values =0.72, P<0.001) but the
RAST inhibition values were about 300-fold higher than the sandwich ELISA values.
In a European Community study, methods to measure rat and mouse aeroallergens
used in laboratories in the Netherlands (NL), UK, and Sweden were compared.
Samples were collected in triplicate and were divided between the laboratories, where they
were eluted and analyzed. RAST inhibition using patient serum gave RUA values
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several orders of magnitude higher than those obtained using the sandwich ELISA
methods. Polyclonal rabbit antibodies against MUA used in an inhibition RIA gave
values 5-6 times higher than in the sandwich ELISAs. The NL polyclonal ELISAs were
the least sensitive and the inhibition assays were the least specific of the assays. Use of
polyclonal antibodies gave higher values than monoclonal antibodies. Addition of
Tween and BSA increased elution efficiency and storage stability. A major difference
between the assays was the reaction to rodent room extracts: whereas the RUA RAST
inhibition detected rat room ventilator dust similarly to concentrated urine, dust was
detected with 700-800-fold less sensitivity in the ELISA assays. The polyclonal MUA
assays all detected mouse room dust with 30-50-fold less sensitivity to mouse urine.
We concluded that assay set-up and antibody specificity are the most important
factors influencing antigen binding. A thorough standardization of methods to measure
airborne allergen is necessary and may be achieved using a sandwich ELISA assay with
defined and purified antibodies and standard antigens.
Key words: laboratory animal allergy, atopy, IgE, methacholine provocation,
aeroallergen measurement, ELISA, monoclonal antibody, Mus m 1, Rat n 1
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Sammanfattning
Anne Renstrm. Allergy to laboratory animals. Risk factors for development of allergy
and methods for measuring airborne rodent allergens. Arbete och Hlsa 1997; 26.
Mellan 10-50% av personal som arbetar med frsksdjur, frmst rttor och mss,
utvecklar frsksdjursallergi (LAA), med symptom som rinit, gonkonjunktivit, astma
eller urtikaria (nsselutslag), och utvecklar IgE mot djurallergener. Symptomen
uppkommer ofta under de frsta ren med arbete med djur och uppemot hlften av
personerna med symptom har astma. En mlsttning med studien var att bestmma
riskfaktorer fr frsksdjursallergi, srskilt i laboratoriemiljer. Ett andra ml var att
utveckla metoder att mta halter av luftburna allergener.
I en prospektiv studie undersktes 225 laboratorieassistenter under deras studietid.
Tv r efter examen undersktes de som arbetat med frsksdjur igen (n=38, mediantid
fr exponering = 18 mnader). Det fanns indikationer p att atopiker var
underrepresenterade bland de som kom att arbeta med djur. Sju av de exponerade
(18%) hade utvecklat pricktestpositivitet (sensibiliserats) mot gnagare och 8 (21%) hade
haft allergiska symptom i samband med arbete med djuren. De sensibiliserade och/eller
symptomatiska (n=9) hade ftt kad bronkiell reaktivitet jmfrt med vid den frsta
underskningen (P<0.01), och jmfrt med icke verknsliga exponerade (P<0.05).
Frhjt total-IgE (P<0.01) och antal timmar per mnad med exponering (P<0.05) var
riskfaktorer fr LAA.
Risken att utveckla LAA i laboratorier med lga exponeringsniver undersktes i en
tvrsnittsstudie (n=80). En fjrdedel av personal med £4 rs exponering fr rttor eller
mss var sensibiliserade eller symptomatiska jmfrt med hlften av de med >4 rs
exponering. Riskfaktorerer fr LAA var Phadiatop-positivitet, frhjd total-IgE-niv,
allergi mot andra plsdjur, och arbete med mestadels hanrttor eller hanmss. Bland
personal med bde exponering fr handjur och frhjt total-IgE eller positiv Phadiatop
pvisades en 11 gnger s hg frekomst av sensibilisering mot djuren, jmfrt med
personer utan dessa riskfaktorer. Exponering fr handjur, som utsndrar flera hundra
gnger hgre allergenmngder n hondjuren bland gnagare, tycks vara en frbisedd
riskfaktor. ven mycket lga allergenhalter kan vidmakthlla allergiska symptom och
specifikt IgE mot djuren.
Fr att kunna mta luftburna allergener frn rtturin (RUA), utvecklades en
monoklonal sandwich-ELISA, dr de tv monoklonalerna var specifika fr de potenta
Rat n 1-isoallergenerna. En amplifieringsmetod utvecklades, som kade knsligheten i
testet tio gnger, till 0.1 ng/m3 i en-timmes prover insamlade med ett luftflde p 2
l/min. En polyklonal sandwich-ELISA fr att mta musurinallergen (MUA) utvecklades
mot det huvudsakliga allergenkomplexet Mus m 1, med en detektionsniv p 1 ng/m3.
Metoden att mta RUA jmfrdes med en RAST inhibitionsmetod utvecklad i ett
laboratorium i Storbritannien. Luftprover samlades in i bda lnderna, och analyzerades
av bda laboratorierna. Vrdena var korrelerade (r2 fr logaritmerade vrden = 0.72,
P<0.001), men RAST-inhibitions-vrdena lg 300 gnger hgre n sandwich ELISA
vrdena.
I en EG-studie jmfrdes metoder att mta luftburna allergener frn rtta och mus
utvecklade i laboratorier i Nederlnderna, Storbritannien och Sverige. Luftprover
samlades in i triplikat och delades upp mellan laboratorierna dr de extraherades och
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analyzerades. RAST inhibition, dr man anvnder patientserum, gav RUA-vrden som
var flera tiopotenser hgre n de som erhlls med sandwich-ELISA metoderna.
Polyklonala kaninantikroppar mot MUA som anvndes i en inhibitions-RIA gav vrden
5-6 gnger hgre n i sandwich-ELISA-metoderna. Nederlndernas polyklonala
ELISA-metoder var de minst knsliga och inhibitions-metoderna de minst specifika av
metoderna. Anvndning av polyklonala antikroppar gav hgre vrden n monoklonala
antikroppar. Tillsats av Tween och BSA kade extraktionseffektivitet och
lagringsstabilitet. En stor skillnad mellan metoderna visade sig i reaktionen mot extrakt
frn djurrum: RAST-inhibitionsmetoden pvisade rttrumsdamm och koncentrerat
rtturin p likartat stt, medan dammextraktet detekterades med 700-800 gngers mindre
knslighet n rtturin i sandwich ELISA-metoderna. De tre polyklonala MUA-
metoderna pvisade musrumsdamm med 30-50 gngers mindre knslighet n musurin.
Vi drog slutsatsen att val av metod (inhibition eller sandwich), samt specificiteten hos
antikropparna, r de viktigaste faktorerna som pverkar antigensbindningen. En
genomgripande standardizering av metoder r ndvndig och kan stadkommas genom
anvndning av en sandwich-ELISA med definierade och renade antikroppar och
standardextrakt.
Nyckelord: frsksdjursallergi, atopi, IgE, metakolinprovokation, luftprovtagning,
luftburna allergener, ELISA, monoklonala antikroppar, Mus m 1, Rat n 1
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